CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0552
(Tag F0552)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, clinical record review and document review, the facility failed to ensure a resident gave informed consent p...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, clinical record review and document review, the facility failed to ensure a resident gave informed consent prior to administration of a psychotropic medication for 4 of 12 sampled residents (Resident #5, #6, #14 and #12).
Findings include:
Resident #5
Resident #5 was admitted to the facility on [DATE], with diagnoses including major depressive disorder, single episode, unspecified and major depressive disorder, recurrent severe without psych features.
Resident #5's psychotropic physician orders included the following:
-02/23/23 citalopram hydrobromide (brand name Celexa) Oral Tablet 20 milligrams (mg), give 20 mg by mouth one time a day related to major depressive disorder, recurrent severe without psychotic features.
Resident #4's informed consent for Celexa, signed 10/10/22, lacked evidence the resident was informed on the indication for use. In a blank space intended for the diagnosis was the resident's first name.
On 08/10/23 at 3:10 PM, the Minimum Data Set (MDS) Coordinator explained Celexa was the brand name for citalopram hydrobromide, and the resident signed the consent without evidence the resident was informed of the indication for use.
Resident #6
Resident #6 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including insomnia, unspecified, anxiety disorder, unspecified, and major depressive disorder, recurrent, unspecified.
Resident #6's psychotropic physician orders included the following:
-07/06/23 trazodone HCl Oral Tablet 150 mg, give 150 mg by mouth at bedtime for sleep.
A consent for Trazadone was for 100 mg and signed 11/01/22.
On 08/02/23 at 3:49 PM, the Skilled Nursing Facility (SNF) Manager confirmed the informed consent for Trazadone should have been updated upon readmit and when it was increased.
A facility policy titled Resident Rights, dated 11/2016, documented the resident had the right to be informed of their treatment.
Resident #14
Resident #14 was admitted to the facility on [DATE] and readmitted on [DATE] with diagnoses including major depressive disorder, single episode, unspecified and insomnia, unspecified.
Resident #14's psychotropic physician orders documented the following:
-06/09/22 traZODone HCl Tablet 100 MG, give 1 tablet by mouth one time a day related to major depressive disorder, single episode, unspecified.
Resident #14's informed consent, signed 06/09/23, indicated the resident was administered tazadone for insomnia.
On 08/10/23 at 2:05 PM, the Minimum Data Set (MDS) Coordinator verbalized the physician order for Trazadone indicated major depressive disorder was the indication for use.
On 08/10/23 at 2:17 PM, the MDS Coordinator confirmed the consent was given to administer arazadone for insomnia and it did not match the order, therefore, informed consent was not given or obtained for the administration of Trazadone.
Resident #12
Resident #12 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, without behavior/psychosis/mood/anxiety, major depressive disorder, single episode, unspecified, anxiety disorder, unspecified, and insomnia, unspecified.
Resident #12's psychotropic physician orders documented the following:
-07/24/23 LORazepam Oral Concentrate 1 mg/0.5ml (Lorazepam), give 0.5 ml by mouth every six hours as needed (PRN) for anxiety.
Resident #12's Medication Administration Records documented the resident recieved lorazepam on the following dates:
-07/25/23
-07/31/23
-08/01/23
-08/02/23
-08/04/23
-08/05/23
-08/06/23
On 08/10/23 at 2:50 PM, the MDS Coordinator verbalized the resident had recieved Lorazepam two times in July and five times in August.
On 08/10/23 at 2:48 PM, the MDS Coordinator confirmed Resident #12 had not signed an informed consent for the administration of lorazepam and verbalized it was required.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0561
(Tag F0561)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, clinical record review, and document review the facility failed to honor a resident's choice to...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, clinical record review, and document review the facility failed to honor a resident's choice to smoke for 1 of 12 sampled residents (Resident #4).
Findings include:
Resident #4
Resident #4 was admitted to the facility on [DATE], and re-admitted on [DATE], with diagnoses including hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified site, anxiety disorder, unspecified, and unspecified dementia, unspecified severity, with psychotic disturbance.
A Unit Secretary Note dated 11/23/22, documented Resident #4 wanted to go out and smoke and was told by the resident's Public Guardian the resident could not smoke until 12/01/22 due to past actions.
A Nursing Progress Note dated 12/17/22, documented the CNA had informed the Nurse of Resident #4's cigarette case and blanket being burned. No burns noted to resident's skin. The Director of Nursing was informed, and the cigarette breaks for the resident were discontinued for the time being.
A Behavioral Health Services Physician Progress Note dated 06/07/23, documented Resident #4's chief complaint was I want to smoke, and verbalized the resident felt the resident's needs were not met in regard to smoking.
On 07/31/23 at 4:58 PM, Resident #4 explained the facility staff used to take the resident out to the smoking area at certain times of the day to smoke with the other residents. Resident #4 verbalized the facility staff would not allow the resident to smoke, even if the resident was supervised, because the resident had been caught smoking in the resident's room. Resident #4 expressed the resident felt bad because the resident watched the other residents go out and smoke when the resident was not allowed.
On 08/01/23 at 10:12 AM, a Licensed Practical Nurse (LPN1) explained Resident #4 asked to go out and smoke frequently but did not know if the resident had a Smoking Assessment completed. The Smoking Assessment evaluated if the resident required adaptive equipment, supervision, and assistance to light the cigarette. LPN1 verbalized one or two staff supervised the smoking area at any time and there were two cameras which had monitors displayed at the Long-Term Care Nurses' Station for additional monitoring.
On 08/01/23 at 4:10 PM, a Social Worker (SW) explained the SW was aware Resident #4 wished to smoke but was not allowed because the resident had been found smoking in the resident's room on 10/29/22 and had burned a hole in the resident's own blanket and cigarette case while smoking in the dedicated smoking area on 12/17/22. The SW confirmed the Smoking Assessment in the resident's chart was dated 07/12/22 and had not been re-assessed after the two incidents had occurred. The SW explained the SW was responsible to follow up on the enforced smoking restriction and did not.
On 08/02/22 at 12:53 PM, LPN2 explained Resident #4 was required to have supervision when smoking. LPN2 verbalized the resident's Public Guardian decided the resident was not safe to smoke in the smoking area and the Resident was not allowed out to the smoking area or to smoke.
On 08/02/23 at 1:35 PM, the Minimum Data Set (MDS) Coordinator explained a Smoking Assessment was to be completed quarterly after the initial assessment completed on 07/12/22. The MDS Coordinator confirmed responsibility for completing the Smoking Assessment and failed to complete a quarterly Smoking Assessment for Resident #4.
On 08/02/23 at 3:47 PM, the Skilled Nursing Facility (SNF) Manager explained Resident #4 was not allowed to smoke because the resident was a safety risk due to requiring total care assistance. The SNF Manager verbalized Resident #4 had required supervision when smoking because the resident needed assistance to get out to the smoking area and light a cigarette. The SNF Manager explained the facility had discussed purchasing a smoking apron for safety and never followed up.
On 08/02/23 at 4:02 PM, the SNF Manager verbalized Resident #4 had the right to smoke and it was wrong for the facility to take the choice away from the resident.
On 08/09/23 at 5:08 PM, Resident #4's Public Guardian confirmed making the decision to restrict the resident from smoking. The Public Guardian explained if the resident had a guardian, it meant the resident was not competent and could not make their own decisions. The Public Guardian explained facility staff had asked the Public Guardian to stop the resident from smoking because the resident had smoked in the bedroom on one occasion and had burned a blanket on another occasion. The Public Guardian verbalized having the authority to prevent the resident from exercising resident rights.
On 08/10/23 at 2:50 PM, Resident #4 verbalized the resident did not understand why the SNF Manager and the Public Guardian would not allow the resident to smoke. Resident #4 verbalized the resident had smoked for forty years, did not want to stop, was not offered smoking cessation products, and did not think the facility should force the resident to quit smoking.
A facility policy titled Fire Safety-Smoking Policy, revised 03/24/22, documented patients and residents who are not mentally competent may smoke only if accompanied by staff that is capable and assigned to accompany that resident/patient. Patients that are too ill to get out of bed to smoke would be offered a nicotine patch for comfort. The patient and family would be provided with education about the health risks connected with smoking and the patient would be encouraged not to smoke. The patient would be provided with education assistance programs about smoking cessation if a desire to quit was expressed.
A facility policy titled Resident Rights, dated 11/2016, documented the facility must provide equal access to quality care regardless of diagnosis, severity of condition, or payment source. The resident had the right to make choices about aspects of his or her life in the facility that are significant to the resident. The resident had a right to a dignified existence, self-determination, and communication with access to persons and services inside and outside the facility.
A facility policy titled Resident Rights Introduction, revised 08/15/11, documented the facility upheld the resident's right to act as a partner in his/her own care processes.
Cross refence with tag 657, and F689.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
MDS Data Transmission
(Tag F0640)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and document review the facility was out of compliance due to late completion and/or transmission of Minimum ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and document review the facility was out of compliance due to late completion and/or transmission of Minimum Data Set (MDS) assessments, Care Area Assessments (CAA) and/or care plans for 8 of 12 months, starting July, 2022.
Findings include:
[DATE]:
10.00% of admission assessments were submitted late (1 of 10)
10.00% of admission care plans were completed late
Sep 2022:
54.55% of assessments were transmitted late (6 of 11)
[DATE]:
42.86% of assessments were transmitted late (3 of 7)
14.29% of comprehensive assessments were transmitted late (1 of 7)
14.29% of entry tracking records were transmitted late
14.29% of death in facility tracking records were submitted late
[DATE]:
28.57% of assessments were transmitted late (4 of 14)
14.29% of entry tracking records were transmitted late (2 of 14)
[DATE]:
47.06% of comprehensive assessments were transmitted late (8 of 17)
35.29% of assessments were transmitted late (6 of 17)
23.53% of care areas assessments were completed late (4 of 17)
[DATE]:
13.33% of assessments were completed late (2 of 15)
13.33% of admission assessments were completed late
13.33% of admission care plans were completed late
13.33% of entry tracking records were transmitted late
[DATE]:
20.00% of assessments were completed late (2 of 10)
[DATE]:
46.67% of assessments were transmitted late (7 of 15)
20.00% of comprehensive assessments were transmitted late (3 of 15)
20.00% of admission assessments were completed late
20.00% of admission care plans were completed late
13.33% of entry tracking records were transmitted late (2 of 15)
On 08/10/23 at 1:45 PM, the Minimum Data Set (MDS) Registered Nurse confirmed the MDS transmissions were submitted late.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Care Plan
(Tag F0656)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, interview, and document review the facility failed to ensure a care plan was developed related ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on clinical record review, interview, and document review the facility failed to ensure a care plan was developed related to 1) wound care for a resident with pressure ulcers for 1 of 12 sampled residents (Resident #17), 2) the use and monitoring of high-risk medications for 1 of 12 sampled residents (Resident #4), 3) the administration of psychotropic medications to include specific behaviors associated with the administration for 4 of 11 residents (Resident #4, #12, #3, and #6) reviewed for unnecessary medications, and 4) a resident requiring pain management for 1 of 12 sampled residents (Resident #10).
Findings include:
Pressure Ulcers
Resident #17
Resident #17 was admitted to the facility on [DATE], with diagnoses including moderate protein-calorie malnutrition, multiple sclerosis, and pressure ulcer of sacral region, stage I.
Resident #17's physician order for Vitamin C documented the following:
-4/21/23, Vitamin C 500 milligrams (mg), give 500 mg by mouth two times a day to aid in wound healing for 14 days, discontinued 05/05/23.
-06/23/23, Vitamin C 500 mg, give 500 mg by mouth two times a day to aid in wound healing for 14 days, discontinued 07/07/23.
-07/17/23, Vitamin C 500 milligrams mg, give 500 mg by mouth two times a day to aid in wound healing for 14 days.
Resident #17's physician order dated 05/18/23, documented Zinc oral tablet 50 mg, give one tablet by mouth one time a day for skin integrity.
Resident #17's physician order dated 07/13/23, documented to encourage resident to change positions frequently to keep pressure off, monitor sacral area, and offer warm, moist compresses twice daily for 15 minutes to raised boggy area on sacral area.
A Resident Skin Evaluation dated 07/20/23, documented Resident #17 had two small open holes in the left gluteal fold.
A Resident Skin Evaluation dated 07/27/23, documented open area on coccyx, wound nurse aware.
A Minimum Data Set Assessment (MDS) 3.0 dated 04/21/23, Section M0210, documented Resident #17 had one or more unhealed pressure ulcers/injuries. Section M0300, documented the resident had a stage I pressure injury and defined stage I as intact skin with non-blanchable redness of a localized area, usually over a bony prominence.
Resident #17's Comprehensive Care Plan lacked identification, care, and treatment of wounds or pressure ulcers.
On 08/01/23 at 10:54 AM, a Registered Nurse (RN) verbalized Resident #17's pressure ulcer started as redness and was now an open wound. The RN explained the resident received wound care from a wound care nurse.
ON 08/02/23 at 3:07 PM, a Licensed Practical Nurse (LPN), who was also the wound care nurse, explained Resident #17 's care plan did not include wound care, pressure ulcers, or the interventions used for either skin condition. The LPN verbalized the risk of skin breakdown/impairment and wound care should have been on the resident's care plan and was not. The LPN defined the purpose of the care plan was a document which laid out the residents' care. The residents' care and anything that may have happened to the resident should be on the care plan.
On 08/02/23 at 3:15 PM, the Skilled Nursing Facility (SNF) Manager explained Resident #17's care plan lacked pressure ulcer prevention and treatment and should have been included on the care plan. The SNF Manager defined the purpose of the care plan was to be a guide for resident care and it was to be person-centered regarding the resident's likes/dislikes.
High Risk Medications
Resident #4
Resident #4 was admitted to the facility on [DATE], and re-admitted on [DATE], with diagnoses including hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified site, anxiety disorder, unspecified, and unspecified dementia, unspecified severity, with psychotic disturbance.
Resident #4's clinical record documented the following physician orders:
-07/04/23, Novolin R (insulin regular human) injection solution 100 unit per milliliter (ml), inject as per sliding scale subcutaneously two times a day related to type II diabetes mellitus, without complications.
-07/06/23, Lantus Solostar subcutaneous solution pen-injector 100 unit/ml, inject 21 unit subcutaneously one time a day related to type II diabetes mellitus, without complications.
On 08/03/23 at 10:01 AM, a Licensed Practical Nurse (LPN) verbalized the expectation for insulin medications was to be included on the resident's care plan and should have included interventions, signs and symptoms monitoring, side effect monitoring, and medication efficacy for specific symptoms. The medications should be care planned to provide guidance for each specific medication that required monitoring for each type of insulin used. The LPN confirmed Resident #4 did not have a care plan specific to the use of insulin and should have.
On 08/10/23 at 2:34 PM, the Assistant Director of Nursing (ADON) verbalized the resident's care plan should identify medications by name and include the diagnosis the medications treated. The ADON explained the facility care plans were general and not resident or medication specific.
Psychotropic medications
Resident #4
Resident #4's clinical record documented the following psychotropic order:
-07/03/23, Mirtazapine oral tablet 7.5 mg, give 7.5 mg by mouth at bedtime related to insomnia, unspecified.
Resident #4's clinical record lacked documented evidence of a resident-centered care plan for the diagnosis of insomnia, unspecified, the use of a psychotropic to treat the diagnosis, or monitoring for specific behaviors or adverse effects related to the medication.
On 08/03/23 at 10:03 AM, an LPN confirmed Resident #4 did not have a care plan specific to the diagnosis of insomnia, the specific medication prescribed, interventions used, behavior monitoring, and signs and symptoms monitoring related to the use of a psychotropic medication and should have.
Resident #12
Resident #12 was admitted to the facility on [DATE], and re-admitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, major depressive disorder, single episode, unspecified, and anxiety disorder, unspecified.
Resident #12's psychotropic physician orders included the following:
-Lorazepam oral concentrate 1 mg/0.5 ml, give 0.5 ml by mouth every 6 hours as needed for anxiety.
-10/04/22, Zoloft tablet 25 mg, give 1 tablet by mouth one time a day related to major depressive disorder, single episode, unspecified and anxiety disorder, unspecified.
Resident #12's care plan for psychotropic medications related to depression, initiated on 06/16/23, documented the following:
-Resident #12 was prescribed an antidepressant.
-Any pharmacy recommendations be given to provider to make determinations.
-Resident #12 continued to be monitored by Behavior Health Services (BHS) psychiatry.
-Resident #12 was given medication as prescribed.
-Non-medication interventions were continued to be provided.
Resident #12's care plan for the diagnosis of anxiety disorder, initiated 05/04/22, included the following:
-Assist with verbalization of feelings.
-Continue to encourage normal daily routines
-Resident #12 continue counseling through BHS.
-Encourage to engage in conversation with fellow residents.
-Offer a cold damp wash cloth for resident #12 to wipe their face.
-Per conversation with counselor, offer Resident #12 a piece of ice to hold in their hand for 10 seconds.
-Staff support resident #12 through active listening skills.
On 08/10/23 at 11:24 AM, an LPN explained behavior monitoring included breathing, hypotension, alertness, and anything to do with the central nervous system. The LPN verbalized behavior monitoring, and documentation was not medication specific and only documented an observed behavior and interventions used for that behavior. The LPN confirmed the electronic health record did not include medication specific behavior monitoring.
On 08/10/23 at 2:36 PM, the ADON verbalized behavior monitoring was generalized for all residents. The ADON explained the staff knew the residents well and knew what to watch for, however the staff did not document very well in the clinical record.
Resident #3
Resident #3 was admitted to the facility on [DATE], with diagnoses including bipolar disorder, unspecified, major depressive disorder, single episode, unspecified, other specified mental disorders due to known physiological condition, and other specified problems related to psychosocial circumstances.
Resident #3's psychotropic physician orders include the following:
-10/27/22 Effexor XR Capsule Extended Release 24 Hour 75 mg, give three capsules by mouth one time a day related to bipolar disorder, unspecified.
-10/27/22 Mirtazapine Tablet 15 mg, give one tablet by mouth at bedtime related to major depressive disorder, single episode, unspecified.
-10/27/22 Aripiprazole Tablet 2 mg, give one tablet by mouth at bedtime related to bipolar disorder, unspecified.
Resident #3's care plan for the psychotropic medications, initiated on 11/03/22, and revised on 06/16/23, documented the following:
Resident #3 was prescribed Effexor, Aripiprazole, and Mirtazapine to help.
alleviate signs and symptoms of bipolar and major depression disorder.
-Resident #3 took medications as prescribed.
-Medications taken to provide a therapeutic affect.
-Blood levels were within normal range.
-Resident #3's provider/Medical Director (MD) was to be given pharmacy recommendations and make following determination.
-Maintain overall good mood/behavior.
-Medications were to be monitored and assessed by the pharmacist, provider, and BHS psychiatry.
-Monitor and report if any side effects or physical conditions occurred as a result of long-term use.
Resident #3's care plan for Bipolar and Major Depression Disorder, initiated on 11/03/22, documented the following:
-Resident #3 utilized coping skills.
-Resident #3 was able to socialize and communicate thoughts and feelings.
-Resident #3 expressed overall having a positive mental wellbeing.
-Resident #3 continued to be monitored by the resident's provider and BHS psychiatry.
-Resident #3 was aware of BHS counseling services and agreed to notify staff if the resident would like to receive additional support.
-Resident #3 was encouraged to express thoughts and feelings.
-Resident #3 participated in activities such as bingo and outings as well as provided individual activities based on her preferences such as puzzles, crossword puzzles, etc.
-Resident #3 socialized with fellow residents.
-Resident #3 understood counseling services were available with BHS.
-Encourage and support Resident #3 to continue daily exercise routine.
On 08/02/23 at 4:06 PM, the Skilled Nursing Facility (SNF) Manager verbalized there were no specific behaviors indicated on Care Plans or physician orders, related to psychotropics. Physicians wrote orders for diagnosis only. Nurses were responsible for identifying behaviors but did not associate the specific behavior with a specific diagnosis in conjunction with a psychotropic medication.
Resident #6
Resident #6 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including insomnia, unspecified, anxiety disorder, unspecified, and major depressive disorder, recurrent, unspecified.
Resident #6's psychotropic physician orders included the following:
-07/16/23 Duloxetine HCl Oral Capsule Delayed Release Particles 60 mg, give one capsule by mouth two times a day related to major depressive disorder, recurrent, unspecified.
-07/25/23 busPIRone HCl Oral Tablet 15 mg, give one tablet by mouth every six hours related to major depressive disorder, recurrent, unspecified.
-07/06/23 Abilify Oral Tablet 5 mg, give 2.5 mg by mouth one time a day related to major depressive disorder, recurrent, unspecified.
-07/06/23 trazodone HCl Oral Tablet 150 mg, give 150 mg by mouth at bedtime for sleep.
Resident #6's care plan for the psychotropic medications, initiated on 08/06/21, documented the following:
-Resident #6 took prescribed antidepressant and anxiety medications Buspirone, Abilify, and duloxetine medications for depression and anxiety.
-Monitor drug blood levels as per orders.
-Monitor interaction or resident with others for appropriateness.
-Monitor resident's mental status on ongoing basis.
-Monitor Resident #6's mood, state, and behavior.
Resident #6 care plan for diagnosis of insomnia reporting not sleeping well at night. initiated 06/16/23, documented the following interventions:
-Resident #6 was to be provided non-medication interventions to help provide quality of sleep.
-Continue to encourage Resident #6 with activities during the day with preferred
independent activities or when there are outings in the community.
-Encourage Resident #6 to do exercises.
-Resident #6 preferred to sleep with the TV on in a darkened room at night.
-Resident #6 took medication to help with sleeping at night.
On 08/02/23 at 4:05 PM, the SNF Manager verbalized Resident #6's specific non-medication interventions included headphones and tablet. The specific interventions should have been listed on the care plan for sleeping but were not. The specific medication for sleep was not listed.
On 08/02/23 at 4:06 PM, the SNF Manager confirmed the psychotropic medications listed on Resident #6's care plan did not reflect which medication was administered for a specific diagnosis and the behavior associated with the diagnosis.
Pain management
Resident #10
Resident #10 was admitted to the facility 09/01/21, and readmitted on [DATE], with diagnoses including type 2 diabetes mellitus without complications.
On 07/31/23 at 12:24 PM, Resident #10 verbalized having had pain in the resident's right hand. The resident requested to end the interview due to the pain.
On 07/31/23 at 2:07 PM, the resident verbalized having been in extreme pain in the right hand and was awaiting an X-ray. The resident was repeatedly pressing the call bell.
The nursing progress note, dated 07/31/23, documented the resident complained of right-hand pain. The Supervisor assessed the resident. The area of concern was noted to right hand thumb where the resident propped up the resident's weight while in bed. X-ray was ordered and the results were pending.
The Medication Regimen Review (Pharmacist's Review), dated 7/31/23, documented the resident complained of right-hand pain, X-ray ordered, results were pending. Provider started the resident on Norco PRN (as needed.)
Resident #10's physician orders for pain were as follows:
-01/04/23 Voltaren Gel 1 % (Diclofenac Sodium) apply to shoulders topically every 24 hours as needed for arthritic shoulder pain.
-11/14/22 Tylenol tablet 325 mg (Acetaminophen), give one tablet by mouth every four hours as needed for pain.
-07/31/23 Norco Oral tablet 5-325 mg, give one tablet by mouth every eight hours as needed for pain related to hereditary and idiopathic neuropathy, unspecified for two days.
On 08/03/23 at 10:51 AM, a Licensed Practical Nurse (LPN) confirmed pain required a care plan. The care plan would indicate the required medications and side effects, evaluation of pain level, what would increase the pain or what decreased the pain, and any comfort measures such as ice packs prior to administering meds.
The LPN confirmed Resident #10 exhibited pain and explained the pain was currently located in the resident's right thumb. The X-ray and Norco were ordered. The resident also had an order for Voltaren gel for shoulder pain. The resident sometimes had headaches.
On 08/03/23 at 10:57 AM. the LPN confirmed the location of Resident #10's pain and management of the pain had not been identified in the resident's care plan.
On 08/03/23 at 11:15 AM, the SNF Manager verbalized pain management should be care planned. The care plan would include location of pain, type of pain, non-pharmacological strategies to alleviate pain and the prescribed medications. The SNF Manager explained Resident #10 had increased pain in the past week to the right thumb and previously had pain in left shoulder.
On 08/03/23 at 11:19 AM, the SNF Manager confirmed Resident #10 did not have a care plan specific for pain management.
The facility policy titled Care Plans, revised 03/22/17, documented the care plan must include the instructions needed to provide effective person-centered care of the resident that met professional standards of quality care. The comprehensive person-centered care plan was consistent with the resident's rights that included measurable objectives and timeframes to meet a resident's medical, nursing, mental and psychosocial needs that were identified in the comprehensive assessment, and a description of services that were to be furnished to attain or maintain the resident's highest practicable physical, mental, and psychosocial well-being.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0657
(Tag F0657)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Resident #4
Resident #4 was admitted to the facility on [DATE], and re-admitted on [DATE], with diagnoses including hemiplegia a...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Resident #4
Resident #4 was admitted to the facility on [DATE], and re-admitted on [DATE], with diagnoses including hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified site, anxiety disorder, unspecified, and unspecified dementia, unspecified severity, with psychotic disturbance.
A Smoking assessment dated [DATE], documented Resident #4 had cognitive loss, had a dexterity problem, did not require supervision or assistance, and the plan of care was used to assure the resident was safe while smoking.
Resident #4's care plan lacked documentation of the Smoking Assessment completion, results, or interventions identified from the assessment.
On 08/01/23 at 4:10 PM, a Social Worker (SW) confirmed Resident #4's Smoking Assessment was dated 07/12/22 and had not been re-assessed since then or upon re-admission.
On 08/02/23 at 1:36 PM, the MDS Coordinator explained a Smoking Assessment was supposed to be completed quarterly, after the initial assessment was completed on 07/12/22, for Resident #4. The MDS Coordinator confirmed responsibility for completing the Smoking Assessment and verbalized a quarterly Smoking Assessment was not completed upon Resident #4's readmission.
On 08/02/23 at 3:48 PM, the SNF Manager verbalized Resident #4 required supervision when smoking because the resident needed assistance to ambulate to the smoking area, and to light a cigarette. The SNF Manager explained Resident #4 was not allowed to smoke because the resident's safety was at risk. The resident's safety risk assessment and assistance requirement were not documented or updated on the care plan. The SNF Manager confirmed Resident #4 had not received another Smoking Assessment upon re-admission and should have.
On 08/09/23 at 4:06 PM, the SW verbalized the care plan for smoking had been removed from Resident #4's care plan completely. The SW communicated the care plan for smoking should have been updated and did not know why it had been removed. The SW explained the MDS Coordinator was responsible to update the care plan with Smoking Assessment.
On 08/09/23 at 4:22 PM, the MDS Coordinator confirmed the Smoking Assessment did not identify the resident as a safety risk, was not added to the care plan, and had not been completed in a timely manner. The MDS Coordinator verbalized the MDS Coordinator was responsible to perform the Smoking Assessment and to update the care plan with the results.
On 08/09/23 at 4:24 PM, the MDS Coordinator confirmed smoking was removed from Resident #4's care plan. The MDS Coordinator explained having determined the Smoking Assessment required improvement and therefore removed the entire section from Resident #4's care plan. The MDS Coordinator verbalized the resident was not allowed to smoke until smoking safety could be determined and was not in a position to make the determination of the resident's smoking status until the SNF Manager returned.
Resident #4's care plan lacked revision and updates upon readmission and documentation of the smoking assessment, to include the evaluation of cognitive ability, judgement, manual dexterity, and mobility.
Resident #4's care plan initiated on 11/02/22, and revised on 02/02/23, documented:
-10/29/22, the resident was caught smoking in the resident's room by staff.
-12/17/22, the resident was found with cigarette burns on their blanket, which was on the resident's lap, along with cigarette burns on the resident's cigarette case. Therefore, it was determined and agreed upon by the Skilled Nursing Facility and the resident's guardian, the resident was unsafe to smoke. Smoking privileges were revoked at this time.
Interventions for Resident #4 were documented as follows:
-11/03/22, Resident #4 followed smoking policy by keeping cigarettes and lighters behind the CNA desk.
-11/03/22, Smoking restriction would be lifted if the resident met the smoking safety assessment. Staff would use active measures to assist with monitoring cigarettes and ensure lighters were kept at the CNA desk.
-11/03/22, and revised 05/03/23, while the resident was on smoking restriction, the resident was informed of reasoning due to safety risks of self and others being unable to follow smoking policies.
Resident #4's care plan lacked documentation of an update or outcome of the imposed smoking restriction on the previous admission.
On 08/02/23 at 1:02 PM, the SW verbalized Resident #4 had been on a 30 day smoking restriction for not following the facility smoking policy last year. The SW confirmed the SW did not follow up on the resident's smoking restriction after the 30 days had passed, the smoking restriction was not lifted, and another Smoking Assessment was not completed after the smoking restriction was initiated or upon readmission. The SW verbalized the SW had forgotten to update the care plan to include the resident's choice to smoke, interventions in place to facilitate the resident's choice to safely smoke, and an updated outcome to the smoking restriction.
On 08/09/23 at 4:07 PM, the SW verbalized the care plan for smoking had been removed from Resident #4's care plan completely. The SW communicated the care plan for smoking should have been updated and did not know why it had been removed. The SW explained the MDS Coordinator was responsible to update the care plan with Smoking Assessment results.
On 08/09/23 at 4:23 PM, the MDS Coordinator confirmed smoking was removed from Resident #4's care plan due to inaccuracies. The MDS Coordinator explained having determined the Smoking Assessment required improvement and therefore removed the entire smoking section from Resident #4's care plan. The MDS Coordinator verbalized the resident was not allowed to smoke until smoking safety could be determined and was not able to make the determination of the resident's smoking status until the SNF Manager returned.
The facility policy titled Care Plans, revised 03/22/17, documented the comprehensive person-centered care plan was consistent with the resident's rights that included measurable objectives and timeframes to meet a resident's medical, nursing, mental and psychosocial needs that were identified in the comprehensive assessment, and a description of services that were to be furnished to attain or maintain the resident's highest practicable physical, mental, and psychosocial well-being. The care plans would be updated as the needs of the resident changed and reviewed at least every 92 days by the interdisciplinary team.
The facility policy titled Interdisciplinary Team Plan of Care, dated 04/01/03, documented care plans would be updated at the time of the care conference or on the shift immediately following the conference. Responsibility for each intervention conducted and documentation of resident response and progress toward the goal is decided and designated by the interdisciplinary team.
Based on interview, observation, clinical record review, and document review, the facility failed to ensure a comprehensive care plan for smoking included revisions or updates upon readmission and included documentation of the smoking assessment with evaluation of cognitive ability, judgement, manual dexterity, and mobility for 2 of 12 sampled residents (Resident #6 and #4), a comprehensive care plan for smoking was revised to include an update for an imposed smoking restriction for 1 of 12 sampled residents (Resident #4), and a comprehensive care plan was updated to include interventions for residents' nutrition status for 1 of 12 residents (Resident #5).
Findings include:
Resident #6
Resident #6 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including nicotine dependence, unspecified, uncomplicated, and personal history of nicotine dependence.
On 07/31/23 at 2:01 PM, Resident #6 verbalized the resident was able to smoke when the resident wanted to, and staff did not supervise the resident's smoking.
On 08/01/23 at 4:09 PM, Resident #6 was outside smoking without supervision.
Resident #6's last Smoking Assessment was completed 05/31/22, prior to most recent admission. The following areas were assessed:
-Cognitive
-Vision
-Dexterity
-Frequency
-Safety
Resident #6's comprehensive care plan, initiated 08/06/21 and last revised 11/03/21, for smoking, indicated the following interventions:
-created 08/23/21, a quarterly smoking assessment was to be completed quarterly.
-created 08/06/21, staff to monitor for continued safety.
-created 07/12/22, Resident #6 was able to sustain the resident's nicotine needs using chewing tobacco while unable to go outside to smoke during isolation.
-last revised 05/11/23, Resident #6 understood cigarettes and lighter needed to be kept at the Certified Nursing Assistant desk.
On 08/01/23 at 4:45 PM, the Minimum Data Set (MDS) Coordinator verbalized a smoking assessment was completed annually or if the resident expressed interest in starting to smoke.
The SNF Manager verbalized smoking assessments were completed only upon admission or on onset of a resident's desire to smoke.
On 08/01/23 at 4:51 PM, the SNF Manager verbalized Resident #6's last smoking assessment was completed 05/31/22, prior to most recent admission of 01/23/23 and confirmed the assessment was without quantifying data to determine safety interventions. The data collected on the assessment did not have criteria to determine needed interventions.
On 08/01/23 at 4:48 PM, the MDS Coordinator verbalized the data collected on the smoking assessment did not equate to a score to determine a resident's safety level of smoking.
The facility policy titled, Smoking by Residents, effective 07/01/12, documented all smoking residents were to be evaluated by the medical and nursing staff for the capability of handling their own smoking materials. Assessment shall be documented in the medical record in the resident's care plan and include the evaluation of cognitive ability, judgement, manual dexterity, and mobility. Resident smoking safety was to be reassessed upon change in resident clinical condition.
Resident #6's smoking assessment lacked assessment of mobility.
Resident #6's care plan for smoking lacked revision and updates upon readmission and documentation of the smoking assessment, to include the evaluation of cognitive ability, judgement, manual dexterity, and mobility.
Resident #5
Resident #5 was admitted to the facility on [DATE], with diagnosis including adult failure to thrive, vitamin deficiency, unspecified, and type two diabetes mellitus without complications.
On 07/31/23 at 12:27 PM, Resident #5's lunch tray contained a whole pork chop. The resident verbalized the resident did not have any teeth and would not be able to eat the whole pork chop but was going to try. The resident did not recall if staff normally cut up meat, however the resident would prefer the meat to be cut up.
Resident #5's tray card documented regular, soft texture: smothered pork cutlet with onions, rice pilaf, green beans, wheat dinner roll, and ice cream.
On 07/31/23 at 12:30 PM, a Licensed Practical Nurse (LPN) verbalized a soft diet would contain chopped or ground meat. The LPN confirmed the residents tray card documented the resident would receive a soft texture diet and the resident had received a whole pork chop. The whole pork chop was not part of a soft diet and would be difficult to eat for a resident that did not have teeth.
On 08/03/23 at 10:38 AM, the SNF Manager verbalized Resident #5 was on a soft diet. The SNF Manager confirmed the resident's care plan did not document the resident's diet type and should have.
An Annual Nutrition Assessment date 07/15/23, documented Resident #5 received a regular diet, soft texture.
A physician's order dated 03/17/22, documented diet type: regular, diet type: soft.
Resident #5's Comprehensive Care Plan included a care plan for altered nutritional status. The care plan documented provide and serve diet as ordered. The care plan did not specify the type of diet the resident should have received.
The facility policy Care Plans, revised 03/22/17, documented each resident would have a comprehensive person-centered care plan which would be based on the findings of the comprehensive assessment, include measurable objectives, timeframes to meet a residents' needs, and the care plan would be updated as the residents needs changed.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Accident Prevention
(Tag F0689)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, observations, clinical record review and document review, the facility failed to ensure a resident received ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, observations, clinical record review and document review, the facility failed to ensure a resident received supervision and assistance to prevent a resident from burning a blanket and cigarette case on the resident's person for 1 of 12 sampled residents (Resident #4), and ensure a smoking resident had a smoking assessment completed quarterly for safety and the assessment determined safety interventions resulting from information gathered on the assessment for 2 of 12 sampled residents (Resident #4 and #6).
Findings include:
Supervision and Assistance and Smoking Assessment
Resident #4
Resident #4 was admitted to the facility on [DATE], and re-admitted on [DATE], with diagnoses including hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified site, anxiety disorder, unspecified, and unspecified dementia, unspecified severity, with psychotic disturbance.
A Certified Nursing Assistant (CNA) Progress Note dated 10/18/22, documented Resident #4 was found outside at 7:30 PM and hollering about wanting to come inside. The CNA was told upon shift change the resident had been outside since noon that day.
A CNA Progress Note dated 10/28/22, documented Resident #4 was found laying in bed and smoking a cigarette in the resident's room while wearing oxygen. The cigarette and lighter were removed from the resident.
A CNA Progress Note dated 12/03/22, documented Resident #4 was taken to the smoking shed at 2:30 PM, left with two cigarettes, and the resident returned at 4:30 PM.
A CNA Progress Note dated 12/17/22, documented the resident was taken to smoke at 10:22 AM and left in the smoke shack. The resident was brought back in at 11:15 AM and was found to have melted a hole in their blanket and cigarette case. The situation was reported to the nurse, Activities Dept, and the Director of Nursing (DON).
A Nursing Progress Note dated 12/17/22, documented the LPN was informed by a CNA the resident had burned their cigarette case and blanket. No burns noted to the resident's skin. The LPN informed the DON and cigarette breaks were discontinued.
On 07/31/23 at 4:57 PM, Resident #4 explained the facility staff used to take the resident out to the smoking area to smoke with the other residents. Resident #4 verbalized the facility staff would not allow the resident to smoke, even if the resident was supervised, because the resident had been caught smoking in the resident's room last year. Resident #4 expressed the resident felt bad because the resident watched the other residents go out and smoke when the resident was not allowed.
On 08/02/22 at 12:53 PM, a Licensed Practical Nurse (LPN) explained Resident #4 was required to have supervision when smoking.
On 08/02/23 at 3:48 PM, the Skilled Nursing Facility (SNF) Manager verbalized Resident #4 was supposed to be supervised in the smoking area because the resident required total care assistance and help to get out to the smoking area and light a cigarette. The resident had verbalized the resident did not want staff to babysit the resident in the smoking area. The SNF Manager explained staff tried leaving the resident outside without supervision and the resident burned their cigarette case and blanket. The SNF Manager verbalized the facility was looking into obtaining a smoking apron for safety and did not purchase the apron.
On 07/31/23 at 4:59 PM, Resident #4 verbalized the resident wanted to smoke but was not allowed to smoke outside and with the other residents. Resident #4 explained facility staff did not allow the resident to smoke since last year because the resident had been caught smoking in the resident's room once and at another time had burned the resident's blanket while smoking.
Resident #4's last Smoking Assessment was completed 07/12/22, prior to the resident's most recent admission, assessed the following:
-Cognitive
-Vision
-Dexterity
-Frequency
-Safety
Resident #4's care plan for smoking, initiated on 11/03/22, documented the resident was caught smoking in the resident's room on 10/29/22 and burned the resident's lap blanket and cigarette case on 12/17/22. An intervention, dated 11/03/22, documented when the smoking restriction was lifted, and if the resident met the Smoking Safety Assessment, staff would use active measures to assist with monitoring cigarettes and ensure lighters were kept at the Certified Nursing Assistant (CNA) desk.
On 08/02/23 at 1:36 PM, the Minimum Data Set (MDS) Coordinator verbalized being responsible to complete the Smoking Assessments on admission, quarterly, and when a resident indicated an interest to start smoking. The MDS Coordinator confirmed Resident #4's last Smoking Assessment was performed on 07/12/22 and should have been completed after the resident had smoked in the resident's room on 10/29/22, after the resident burned holes in their blanket and cigarette case on 12/17/22, quarterly, and upon re-admission and was not done.
On 08/02/23 at 3:51 PM, the SNF Manager verbalized the facility had not performed a Smoking Assessment since 07/12/22 and should have re-assessed the resident for safety after the two incidents last year and upon re-admission.
On 08/09/23 at 4:21 PM, the MDS Coordinator confirmed the Smoking Assessment did not identify the resident as a safety risk and had not been completed in a timely manner.
Resident #4's Smoking Assessment lacked assessment of mobility.
The facility policy titled Resident Rights, dated 11/2016, documented the resident had the right to a safe, clean, comfortable, and homelike environment, including receiving treatment and support for daily living safely.
Cross Reference with tag F561.
Resident #6
Resident #6 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including nicotine dependence, unspecified, uncomplicated, and personal history of nicotine dependence.
On 07/31/23 at 2:01 PM, Resident #6 verbalized the resident was able to smoke when the resident wanted to, and staff did not supervise the resident's smoking.
On 08/01/23 at 4:09 PM, Resident #6 was outside smoking without supervision.
Resident #6's last Smoking Assessment was completed 05/31/22, prior to most recent admission. The following areas were assessed:
-Cognitive
-Vision
-Dexterity
-Frequency
-Safety
Resident #6's comprehensive care plan, initiated 08/06/21, for smoking, indicated an intervention created 08/23/21, a quarterly smoking assessment was to be completed quarterly and staff monitor for continued safety.
On 08/01/23 at 4:45 PM, the SNF Manager explained smoking assessments were completed to make sure residents were safe to smoke.
The Minimum Data Set (MDS) Coordinator verbalized a smoking assessment was completed annually or if the resident expressed interest in starting to smoke.
The SNF Manager verbalized smoking assessments were completed only upon admission or on onset of a resident's desire to smoke.
On 08/01/23 at 4:51 PM, the SNF Manager verbalized Resident #6's last smoking assessment was completed 05/31/22, prior to most recent admission of 01/23/23 and confirmed the assessment was without quantifying data to determine safety interventions. The data collected on the assessment did not have criteria to determine needed interventions.
The SNF Manager verbalized the SNF Manager tracked the timeliness of other assessments but there had been no need to track the timeliness of smoking assessments.
On 08/01/23 at 4:48 PM, the MDS Coordinator verbalized the data collected on the smoking assessment did not equate to a score to determine a resident's safety level of smoking.
On 08/01/23 at 4:50 PM, the MDS Coordinator verbalized the smoking assessments should have been tracked to be completed quarterly.
The facility policy titled, Smoking by Residents, effective 07/01/12, documented all smoking residents were to be evaluated by the medical and nursing staff for the capability of handling their own smoking materials. Assessment shall be documented in the medical record in the resident's care plan and include the evaluation of cognitive ability, judgement, manual dexterity, and mobility.
Resident #6's smoking assessment lacked assessment of mobility.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0692
(Tag F0692)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, clinical record review, and document review, the facility failed to provide a therapeutic diet ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, clinical record review, and document review, the facility failed to provide a therapeutic diet for an edentulous resident for 1 of 12 sampled residents (Resident #5).
Findings include:
Resident #5
Resident #5 was admitted to the facility on [DATE], with diagnoses including adult failure to thrive, vitamin deficiency, unspecified, and type two diabetes mellitus without complications.
On 07/31/23 at 12:27 PM, Resident #5's lunch tray contained a whole pork chop. The resident verbalized the resident did not have any teeth and would not be able to eat the whole pork chop but was going to try. The resident did not recall if staff normally cut up meat, however the resident would prefer the meat to be cut up.
Resident #5's tray card documented regular, soft texture: smothered pork cutlet with onions, rice pilaf, green beans, wheat dinner roll, and ice cream.
On 07/31/23 at 12:30 PM, a Licensed Practical Nurse (LPN) verbalized a soft diet would contain chopped or ground meat. The LPN confirmed the resident's tray card documented the resident would receive a soft texture diet and the resident had received a whole pork chop. The whole pork chop was not part of a soft diet and would be difficult to eat for a resident that did not have teeth.
On 08/01/23 at 3:55 PM, a Personal Care Technician (PCT) verbalized Resident #5 had problems eating due to not having teeth. The PCT explained the resident usually received whole pieces of meat and the PCT would chop the meat when the resident asked.
On 08/02/23 at 8:51 AM, the Dietary Manager (DM) verbalized a soft diet consisted of soft textured foods such as chopped meats. The DM explained dry meats such as chicken or pork should be chopped with gravy for a resident on a soft diet. The DM confirmed Resident #5 was to receive a soft diet. The DM verbalized a whole pork chop would not meet the criteria for a soft diet.
On 08/03/23 at 10:38 AM, the Registered Dietician (RD) explained a soft diet was a texture modified diet with chopped or ground meats and soft mushy vegetables. A resident on soft diet should never receive a whole piece of pork loin. The RD confirmed Resident #5 had poor dentition and should receive meats chopped up or ground.
An Annual Nutrition assessment dated [DATE], documented Resident #5 received a regular diet, soft texture.
A physician's order dated 03/17/22 documented diet type: regular, diet type: soft.
The facility policy titled Texture Consistency, dated 10/05/17, documented the food and nutrition services department would be responsible for preparing and serving diet textures as ordered.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0697
(Tag F0697)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, observation, clinical record review and document review, the facility failed to ensure a resident's pain was...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, observation, clinical record review and document review, the facility failed to ensure a resident's pain was managed with care planned interventions, pain was evaluated per a physician order, and appropriate administration of pain medication for 1 of 12 sampled residents (Resident #10).
Findings include:
Resident #10
Resident #10 was admitted to the facility 09/01/21, and readmitted on [DATE], with diagnoses including type 2 diabetes mellitus without complications.
On 07/31/23 at 12:24 PM, Resident #10 verbalized having had pain in the resident's right hand. The resident had requested Voltaren gel for the resident's right hand. The resident requested to end the interview due to the pain. A Registered Nurse entered the resident's room and applied the Voltaren gel to the resident's right hand.
On 07/31/23 at 2:07 PM, the resident verbalized having extreme pain in the right hand and was awaiting an X-ray. The resident was repeatedly pressing the call bell.
The nursing progress note, dated 07/31/23, documented the resident complained of right hand pain. The Supervisor assessed the resident. The area of concern was noted to right hand thumb where the resident propped up the resident's weight while in bed. X-ray was ordered and the results were pending.
The Medication Regimen Review (Pharmacist's Review), dated 07/31/23, documented the resident complained of right hand pain, X-ray ordered, results were pending. Provider started the resident on Norco PRN (as needed.)
Resident #10's physician orders for pain were as follows:
-01/04/23 Voltaren Gel 1 % (Diclofenac Sodium) apply to shoulders topically every 24 hours as needed for arthritic shoulder pain.
-11/14/22 Tylenol tablet 325 mg (Acetaminophen), give one tablet by mouth every four hours as needed for pain.
-11/14/22 Evaluate level of pain using 0-10 scale
-07/31/23 Norco Oral tablet 5-325 mg, give one tablet by mouth every eight hours as needed for pain related to hereditary and idiopathic neuropathy, unspecified for two days.
On 08/03/23 at 10:51 AM, a Licensed Practical Nurse (LPN) confirmed pain required a care plan. The care plan would indicate the required medications and side effects, evaluation of pain level, what would increase the pain or what decreased the pain, and any comfort measures such as ice packs prior to administering meds.
The LPN confirmed Resident #10 exhibited pain and explained the pain was currently located in the resident's right thumb. The X-ray and Norco were ordered. The resident also had an order for Voltaren gel for shoulder pain. The resident sometimes had headaches.
On 08/03/23 at 10:57 AM, the LPN confirmed the location of Resident #10's pain and management of the pain had not been identified in the resident's care plan.
On 08/03/23 at 11:01 AM, the LPN confirmed the resident had an active order to evaluate pain but explained it was only evaluated if staff were administering a pain medication.
On 08/03/23 at 11:07 AM, the LPN confirmed the resident received Voltaren gel on 07/31/23 at 12:47 PM, and verbalized it was coded as a five for location, indicative administration of the medication was due to pain in the hand.
On 08/03/23 at 11:11 AM, the LPN verbalized the Voltaren gel was ordered for pain in the resident's shoulder. The LPN verbalized it was administered incorrectly.
On 08/03/23 at 11:15 AM, the SNF Manager verbalized pain management should be care planned. The care plan would include location of pain, type of pain, non-pharmacological strategies to alleviate pain and the prescribed medications. The SNF Manager explained Resident #10 had increased pain in the past week to the right thumb and previously had pain in left shoulder.
On 08/03/23 at 11:19 AM, the SNF Manager confirmed Resident #10 did not have a care plan specific for pain management.
On 08/03/23 at 11:20 AM, the SNF Manager confirmed Resident #10 had an order for evaluation of pain. The SNF Manager verbalized the evaluation of pain was not documented unless the resident requested a PRN pain medication. The order for evaluation of the resident's pain should have been scheduled and documented on the resident's Treatment Administration Record (TAR). The nurse did not input the order correctly to ensure it was evaluated on a schedule. It should have been scheduled for morning and night in addition to the evaluation during a PRN pain medication administration.
On 08/03/23 at 11:25 AM, the SNF Manager admitted the resident had received Voltaren gel for thumb pain on 07/31/23 at 12:47 PM, and it should have only been administered for shoulder pain. A nurse cannot administer medication to a different location then where it was specified on an order.
The facility policy titled Pain Assessment, Treatment and Documentation, revised 01/01/19, documented administration of pain relieving care or medications and their effectiveness were to be accurately and completely documented. A medical provider was to specify the type of pain a medication was intended to treat when more that one pain medication was ordered.
The facility policy titled Pain Management, effective 01/02/19, documented the physician was to be contacted regarding pain or pain indicators, an individualized care plan was to be developed and implemented, and in the event there were no new orders for the pain, licensed staff were to continue to monitor the resident's condition. Alternative methods of pain control were to be attempted.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0727
(Tag F0727)
Could have caused harm · This affected 1 resident
Based on interview and document review the facility failed to ensure the facility had a full-time Director of Nursing (DON).
Findings include:
On 07/31/23 at 11:03 AM, the Administrator verbalized...
Read full inspector narrative →
Based on interview and document review the facility failed to ensure the facility had a full-time Director of Nursing (DON).
Findings include:
On 07/31/23 at 11:03 AM, the Administrator verbalized the facility did not have a DON, however the facility had a Licensed Practical Nurse (LPN) functioning as the Skilled Nursing Facility (SNF) Manager.
On 08/03/23 at 1:28 PM, the Human Resources Director verbalized the facility did not have a DON and the DON position was vacant.
The Facility Assessment Tool, revised 07/19/23, documented to ensure sufficient staff to meet the needs of the residents at any given time one Skilled Nursing Manager, License Practical Nurse (LPN), was to be full-time on days.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Drug Regimen Review
(Tag F0756)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and clinical record review, the facility failed to ensure a physician responded to a pharmacist recommendatio...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and clinical record review, the facility failed to ensure a physician responded to a pharmacist recommendation to add an end date to a psychotropic as needed (PRN) physician's order for 1 of 11 residents receiving psychotropic medications (Resident #12)
Findings include:
Resident #12
Resident #12 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, without behavior/psychosis/mood/anxiety, major depressive disorder, single episode, unspecified, anxiety disorder, unspecified, and insomnia, unspecified.
Resident #12's psychotropic physician orders documented the following:
-07/24/23 Lorazepam Oral Concentrate 1 milligram (mg)/0.5 milliliter (ml) (Lorazepam), give 0.5 ml by mouth every six hours as needed for anxiety.
Resident #12's Medication Regimen Review note, dated 07/31/23, completed by the pharmacist, documented consideration to add duration to PRN lorazepam had been made to the psychotropic medication review form.
On 08/10/23 at 2:40 PM, the Minimum Data Set (MDS) Coordinator verbalized the Lorazepam order should have had a 14 day stop date because it was ordered as needed.
On 08/10/23 at 2:49 PM, the MDS Coordinator explained the physician signed the psychotropic medication review form acknowledging the pharmacist had read the recommendation from the pharmacist to add the end date to the PRN lorazepam. However, the physician did not respond or document a clinical rationale to the pharmacist recommendation. Nursing was not directed to add an end date.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0757
(Tag F0757)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, observation, clinical record review and document review, the facility failed to ensure a resident did not re...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, observation, clinical record review and document review, the facility failed to ensure a resident did not receive an unnecessary pain medication when a nurse administered Voltaren gel for a different location of pain than indicated in a physician order for 1 of 12 sampled residents (Resident #10).
Findings include:
Resident #10
Resident #10 was admitted to the facility 09/01/21, and readmitted on [DATE], with diagnoses including type 2 diabetes mellitus without complications.
On 07/31/23 at 12:24 PM, Resident #10 verbalized having had pain in the resident's right hand. The resident had requested Voltaren gel for the resident's right hand. The resident requested to end the interview due to the pain. The Registered Nurse entered the resident's room and applied the Voltaren gel to the resident's right hand.
The nursing progress note, dated 07/31/23, documented the resident complained of right hand pain. The Supervisor assessed the resident. The area of concern was noted to right hand thumb where the resident propped up the resident's weight while in bed. X-ray was ordered and the results were pending.
Resident #10's physician order dated 01/04/23, documented Voltaren Gel 1 % (Diclofenac Sodium) apply to shoulders topically every 24 hours as needed for arthritic shoulder pain.
On 08/03/23 at 10:51 AM, a Licensed Practical Nurse (LPN) confirmed Resident #10 exhibited pain and explained the pain was currently located in the resident's right thumb. The resident also had an order for Voltaren gel for shoulder pain.
On 08/03/23 at 11:07 AM, the LPN confirmed the resident received Voltaren gel on 07/31/23 at 12:47 PM, and verbalized it was coded as a five for location, indicative of administration of the gel due to pain in the hand.
On 08/03/23 at 11:11 AM, the LPN verbalized the Voltaren gel was ordered for pain in the resident's shoulder. The LPN verbalized it was administered incorrectly.
On 08/03/23 at 11:15 AM, the SNF Manager verbalized Resident #10 had increased pain in the past week to the right thumb and previously had pain in left shoulder.
On 08/03/23 at 11:25 AM, the SNF Manager admitted the resident had received Voltaren gel for thumb pain on 07/31/23 at 12:47 PM, and it should have only been administered for shoulder pain. A nurse cannot administer medication to a different location then where the pain was specified on an order.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Administration
(Tag F0835)
Could have caused harm · This affected 1 resident
Based on interview and document review the facility failed to ensure the facility had a full-time Director of Nursing (DON), resulting in a lack of clinical oversight for safe bedrail implementation, ...
Read full inspector narrative →
Based on interview and document review the facility failed to ensure the facility had a full-time Director of Nursing (DON), resulting in a lack of clinical oversight for safe bedrail implementation, and psychotropic medications.
Findings include:
Full-time DON
On 07/31/23 at 11:03 AM, the Administrator verbalized the facility did not have a DON, however the facility had a Licensed Practical Nurse (LPN) functioning as the Skilled Nursing Facility (SNF) Manager. The Administrator explained the SNF Manager was in a nursing program and would become a Registered Nurse in May of 2024.
On 08/01/23 at 9:36 AM, a Registered Nurse (RN) verbalized the SNF Manager was the charge nurse.
On 08/03/23 at 1:28 PM, the Human Resources Director verbalized the facility did not have a DON and the DON position was vacant.
On 08/09/23 at 3:59 PM, an RN verbalized the SNF Manager was the Charge Nurse and the RN took clinical direction from the SNF Manager.
On 08/09/23 at 4:20 PM, the Assistant Director of Nursing (ADON)/RN verbalized the Charge Nurse supervised the care of residents and ensured policies and procedures were followed. The Charge Nurse supervised and provided clinical guidance to the staff. The ADON confirmed the SNF Manager was the Charge Nurse and was an LPN. The ADON confirmed an LPN cannot clinically supervise an RN.
On 08/09/23 at 4:45 PM, the Minimum Data Set (MDS) Nurse/RN verbalized the SNF Manager was an LPN. The MDS RN confirmed the SNF Manager was the Charge Nurse and the MDS RN's direct supervisor.
The SNF Manager job description, revised 04/28/22, documented the SNF Manager performed duties such as completing care plans, supervising all SNF staff, and providing coverage on the floor as the Charge Nurse.
Practical Nurses NAC 632.230 to 632.242, inclusive (Added to NAC by Board of Nursing, effective 11/02/87)
NAC 632.230 Limitations on performance of tasks; supervision of others; delegation of duties.
A licensed practical nurse may not independently carry out those duties which require the substantial judgment, knowledge and skill of a registered nurse.
Bedrails
On 08/02/23 at 9:18 AM, the Skilled Nursing Facility (SNF) Manager verbalized upon admission, if a resident had issues with mobility, the facility would obtain an order from the physician for a halo and have the halo installed. The SNF Manager confirmed the facility did not attempt alternatives prior to installation.
On 08/02/23 at 10:05 AM, the SNF Manager verbalized the Halo Mobility Ring Assessment did not contain an assessment for entrapment. The SNF Manager explained the Halo Mobility Ring Assessment assesses if the resident's head could get stuck but did not assess for overall risk of entrapment.
On 08/02/23 at 10:42 AM, the SNF Manager verbalized the Halo Mobility Ring Assessment had a section of questions, when answered yes, would prompt the facility to complete a restraint assessment, a restraint care plan, and a restraint reduction plan initiated. The SNF Manager confirmed for residents whose assessments indicted a yes as an answer to those questions, restraint assessments and restraint care plans were not completed and restraint reduction plans were not initiated.
On 08/03/23 at 10:55 AM, the SNF Manager verbalized alternatives were not attempted prior to installing bed rails. The SNF Manager explained upon admission, if the resident was unable to get in and out of bed independently, the facility would get an order from the physician for a halo device to be installed. The SNF Manager confirmed residents were given Halo Mobility Rings upon admission, prior to attempting alternatives.
The SNF Manager verbalized residents with Halo Mobility Rings and side rails should have consents explaining the risks and benefits, a physician's order, and care plans for mobility that include the Halo ring. The SNF Manager confirmed not all residents had Halo Mobility Assessments completed, consents that explained the risks and benefits, and care plans for mobility that included the Halo Mobility Ring.
Psychotropic Medications
On 08/02/23 at 1:49 PM, the LPN explained in April 2023, the facility transitioned from monitoring behaviors and side effects on hardcopy flowsheets to monitoring all behaviors electronically. Adverse side effects for psychotropic medications were no longer monitored.
On 08/02/23 at 1:53 PM, the SNF Manager verbalized behavior monitoring was conducted under the behavior tab in the Electronic Medical Record (EMR).
On 08/02/23 at 2:15 PM, the SNF Manager verbalized behavior monitoring was not medication specific since the facility transitioned to documenting behaviors in the EMR. All residents were monitored for all the same behaviors regardless of medications ordered.
On 08/02/23 at 4:06 PM, the Skilled Nursing Facility (SNF) Manager verbalized there were no specific behaviors indicated on Care Plans or physician orders, related to psychotropics. Physicians wrote orders for diagnosis only. Nurses were responsible for identifying behaviors but did not associate the specific behavior with a specific diagnosis in conjunction with a psychotropic medication.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0838
(Tag F0838)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and document review, the facility failed to ensure the last revised Facility Assessment reflected an open Dir...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and document review, the facility failed to ensure the last revised Facility Assessment reflected an open Director of Nursing (DON) position.
Findings include:
The Facility assessment dated [DATE], did not include the open DON position on the facility's staffing plan.
On 08/10/23 at 11:27 AM, the Administrator confirmed the Facility Assessment's staffing plan did not include the open DON position. The Administrator confirmed the Facility Assessment staffing plan should indicate all open positions.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
QAPI Program
(Tag F0867)
Could have caused harm · This affected 1 resident
Based on interview and document review, the facility failed to ensure the Quality Assessment Performance Improvement (QAPI) Committee identified areas of concern related to use of widespread implement...
Read full inspector narrative →
Based on interview and document review, the facility failed to ensure the Quality Assessment Performance Improvement (QAPI) Committee identified areas of concern related to use of widespread implementation of bedside rails and unnecessary psychotropic medications and implemented Performance Improvement Projects (PIPs) to reduce the risk of Substandard Quality of Care (Cross-reference tags F700 and F758).
Findings include:
The facility's Quality Assessment Performance Improvement (QAPI) Plan, undated, documented the QAPI plan addressed clinical care by monitoring existing quality indicator and quality monitor results, internal monitors for falls, medication errors, pressure ulcers, incident reports, infection reports, and adverse events. The QAPI committee was to prioritize topics for PIPs based on the current needs of the residents and the organization. Priority would be given to areas defined as high risk to residents and staff, high prevalence, or high-volume areas, and areas problem prone. Potential topics for PIPs were identified through a prioritization process by the QAPI committee. Review of State/National and past facility measures were to be used to benchmark for improvement in all areas. These benchmarks will be reviewed at least monthly and reported to the QA committee on a quarterly basis. The QA committee monitored progress to ensure interventions or actions were implemented and effective in making and sustaining improvements.
The facility's Minimum Data Set (MDS) 3.0 Facility Level Quality Measure Report dated 01/01/23-06/30/23, indicated antianxiety/hypnotic percentage for use with long-term residents for the Comparison Group National Percentile was flagged at 82 percent and antipsychotic use for long term residents was flagged at 88 percent.
CASPER Report 0004D F133-Number of Residents receiving Psychoactive Drugs, last updated 07/26/23, documented usage at 13 residents at 56.5 percent for the facility.
On 08/10/23 at 3:14 PM, the Risk Manager verbalized the role of Risk Manager was also the Quality Assurance Coordinator for the QAPI committee. The QAPI meeting was conducted monthly.
The QAPI committee did not review CASPER reports to determine issues needing PIPs and monitoring. Significant weight loss, falls, psychotropic drug usage, implementation of bed rails/halo rings were not areas reviewed monthly for consideration for improvement.
On 08/10/23 at 3:26 PM, the Risk Manager verbalized having been in the role for about a year and was not familiar with psychotropic drugs or the implementation of bed rails/halo rings.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Infection Control
(Tag F0880)
Could have caused harm · This affected 1 resident
Based on observation, interview and document review, the facility failed to ensure signage regarding COVID-19 (COVID) was present at the facility's point of entry and at the internal and external entr...
Read full inspector narrative →
Based on observation, interview and document review, the facility failed to ensure signage regarding COVID-19 (COVID) was present at the facility's point of entry and at the internal and external entrance doors of the Long-Term Care (LTC) Unit.
Findings include:
On 07/31/23, 08/01/23, 08/02/23, 08/03/23, 08/09/23, and 08/10/23, the dates of the facility's annual recertification survey, signage related to COVID was not posted at or near the facility's point of entry, the internal LTC Unit entrance, and the LTC Unit external entrance door.
On 08/03/23 at 10:42 AM, the Infection Preventionist (IP) explained the IP was not aware signage related to COVID was needed when the facility was not experiencing an outbreak. The IP verbalized the facility did not have signage related to COVID at the facility's point of entry, at the internal entrance double doors leading to the LTC unit, or at the external entrance door of the LTC unit. The IP explained visitors were verbally educated on self-monitoring for signs and symptoms of COVID, but this occurred after the visitor entered the facility. The IP confirmed the facility followed the Center for Disease Control and Prevention (CDC) infection control guidelines.
The Centers for Medicare and Medicaid Services (CMS) Memo titled QSO-20-39-NH, revised 05/08/23, documented core principles and best practices to reduce the risk of COVID-19 transmission included facility provided guidance (e.g., posted signs at entrances) about recommended actions for visitors who have a positive viral test for COVID-19, symptoms of COVID-19, or have had close contact with someone with COVID-19. Visual alerts (e.g., signs, posters) were posted at the entrance and in strategic places (e.g., waiting areas, elevators, cafeterias). The alerts should include instructions about current Infection Prevention and Control (IPC) recommendations, source control, cleaning and disinfection of frequently touched surfaces, designated visitation areas, appropriate staff use of Personal Protective Equipment (PPE), and effective cohorting of residents in separate areas dedicated to COVID-19 care. The core principles were consistent with the CDC guidance for nursing homes and should be adhered to at all times.
The facility policy titled Covid-19 Facility Testing Policy, revised 05/31/23, documented all areas with direct patient care would follow the appropriate CDC/CMS recommendations. Visitors, patients, and employees were asked to self-screen and monitor for symptoms prior to entry. Patient management strategies would be implemented in accordance with the CDC's recommendations.
The facility policy titled Infection and Prevention Control Annual Plan 2023, dated 2023, documented policies would reflect current accepted and approved infection prevention practices based on regulatory recommendations, standards, and guidelines. Education was provided to patients, visitors, and families with fact sheets and signage.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0942
(Tag F0942)
Could have caused harm · This affected multiple residents
Based on personnel record review, interview and document review, the facility failed to ensure resident rights training was completed by staff for 7 of 20 sampled employees (Employee #1, #6, #10, #11,...
Read full inspector narrative →
Based on personnel record review, interview and document review, the facility failed to ensure resident rights training was completed by staff for 7 of 20 sampled employees (Employee #1, #6, #10, #11, #13, #14, and #16.
Findings include:
Employee #1
Employee #1 was hired as the Administrator on 06/15/22.
Employee #1's personnel record lacked documented evidence of resident rights training.
Employee #6
Employee #6 was hired as the Nutrition Services Supervisor on 11/28/21.
Employee #6's personnel record documented lacked documented evidence resident rights training was completed since hiring date.
Employee #10
Employee #10 was hired as a CNA on 06/01/23.
Employee #10's personnel record lacked documented evidence resident rights training was completed.
Employee #11
Employee #11 was hired as the CNA on 02/20/23.
Employee #11's personnel record lacked documented evidence resident rights training was completed.
Employee #13
Employee #13 was hired as a RN on 06/12/23.
Employee #13's personnel record lacked documented evidence resident rights training had been completed.
Employee #14
Employee #14 was hired as a Licensed Practical Nurse (LPN) on 03/08/23.
Employee #14's personnel record lacked documented evidence resident rights training had been completed.
Employee #16
Employee #16 was hired as a CNA on 07/24/23.
Employee #16's personnel record lacked documented evidence resident rights training had been completed.
On 08/10/23 at 2:53 PM, the Human Resources (HR) Director verbalized all staff were required to complete resident rights training upon hire and annually thereafter. The Business Office Manager confirmed Employees #1, #6, #10, #11, #13, #14, and #16 had not completed timely resident rights training.
CONCERN
(F)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0700
(Tag F0700)
Could have caused harm · This affected most or all residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, clinical record review, and document review, the facility failed to ensure the alternatives wer...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, clinical record review, and document review, the facility failed to ensure the alternatives were attempted, risks and benefits were explained, consents were obtained prior to installation of bedrails or grab bar (Halo ring) and mobility assessments were completed for 15 of 21 residents residing in the facility (Resident #1, #2, #3, #4, #5, #7, #9, #10, #12, #14, #15, #16, #17, #171, and #172).
Resident #1
Resident #1 was admitted to the facility on [DATE] and readmitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety, and falls.
On 07/31/23, Resident #1's bed had a Halo ring on the left side.
Resident #1's physician's order dated 04/19/22, documented may use Halo for bed mobility.
Resident #1's clinical record lacked documented evidence of a Halo Mobility Ring Assessment, an assessment for entrapment, a signed consent with risks and benefits, and alternatives were tried prior to installation.
Resident #2
Resident #2 was admitted to the facility on [DATE] with diagnoses of multiple sclerosis and other seizures.
On 07/31/23, Resident #2's bed had two quarter rails in the up position.
Resident #2's physician's order dated 07/05/23, documented may use side rails for safety.
Resident #2's Bedrail Consent, dated 07/05/23, lacked an explanation of risks and benefits.
Resident #2's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails dated 05/05/23, lacked documented evidence of an assessment for entrapment.
Resident #2's clinical record lacked documented evidence alternatives were tried prior to installation.
Resident #3
Resident #3 was admitted to the facility on [DATE], with diagnoses including adult failure to thrive and pain in left shoulder.
On 07/31/23, Resident #3's bed had two Halo rings on both sides.
Resident #3's physician's order dated 10/27/22, documented may use Halo for bed mobility.
Resident #3's Halo Mobility Ring assessment dated [DATE], lacked documented evidence of an assessment for entrapment.
Resident #3's Bedrail Consent, dated 07/05/23, lacked an explanation of risks and benefits.
Resident #3's clinical record lacked documented evidence alternatives were tried prior to installation.
Resident #3's Comprehensive Care Plan lacked a care plan for side rails and/or Halos.
Resident #4
Resident #4 was admitted to the facility on [DATE] and readmitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, with psychotic disturbance and hemiplegia and hemiparesis following unspecified cerebrovascular disease affecting unspecified side.
On 07/31/23, Resident #4's bed had a Halo ring on each side of the bed.
Resident #4's physician's order, dated 07/03/23, documented may use Halo for bed mobility, the same day as readmission.
Resident #4's clinical record lacked documented evidence alternatives were tried prior to installation.
Resident #4's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails was dated 05/27/21.
The assessment indicated the resident had a diagnosis of dementia, required a low bed or bed alarm for safety from falls and therefore, the device was a restraint.
The assessment was utilized in determining if the device was a restraint. The assessment did not have a determination if the resident was at risk for entrapment.
Resident #4's Bedrail Consent, dated 07/03/23, lacked an explanation of risks and benefits.
Resident #5
Resident #5 was admitted to the facility on [DATE], with diagnosis including adult failure to thrive and fall on same level from slipping, tripping, and stumbling without subsequent striking against object, initial encounter.
On 07/31/23, Resident #5's bed had a Halo ring on each side of the bed.
Resident #5's physician's order dated 08/02/23, documented may use Halo for bed mobility.
Resident #5's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails was dated 08/26/22 and lacked the option to document the answers to the questions for the Restraint vs Activities of Daily Living (ADL) Enabling Device assessment.
Resident #5's clinical record lacked documented evidence of a signed consent that explained the risks and benefits.
Resident #5's clinical record lacked documented evidence alternatives were tried prior to installation.
Resident #5's Comprehensive Care Plan lacked a care plan for side rails and/or Halos.
Resident #7
Resident #7 was admitted to the facility on [DATE] and readmitted on [DATE], with diagnoses including dementia and altered mental status.
On 07/31/23, Resident #7's bed one Halo up on the side.
Resident #7's physician's order dated 08/02/23, documented may use Halo for bed mobility.
Resident #7's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails was dated 10/07/22.
The assessment indicated the resident had a diagnosis of and therefore, the device was a restraint.
Resident #7's clinical record lacked documented evidence of a Restraint Assessment, a restraint care plan, or a restraint reduction plan initiation.
Resident #7's clinical record lacked documented evidence of a signed consent that explained the risks and benefits.
Resident #7's clinical record lacked documented evidence alternatives were tried prior to installation.
Resident #7's Comprehensive Care Plan lacked a care plan for side rails and/or Halos.
Resident #9
Resident #9 was admitted to the facility on [DATE], with a diagnosis of epilepsy.
On 07/31/23, Resident #9's bed had a Halo ring on each side of the bed.
Resident #9's physician's order dated 03/22/23, documented may use Halo for bed mobility.
Resident #9's clinical record lacked documented evidence of a Halo Mobility Ring Assessment, a signed consent that explained risks and benefits, alternatives were tried prior to installation, and a care plan for side rails and/or Halos.
Resident #10
Resident #10 was admitted to the facility on [DATE] and readmitted on [DATE], with a diagnosis of muscle weakness.
On 07/31/23, Resident #10's bed had a Halo on the left side.
Resident #10's physician's order dated 11/14/22, documented may use Halo for bed mobility.
Resident #10's clinical record lacked documented evidence of a Halo Mobility Ring Assessment, a signed consent that explained risks and benefits, alternatives were tried prior to installation, and a care plan for side rails and/or Halos.
Resident #12
Resident #12 was admitted to the facility 12/02/20 and readmitted on [DATE], with a diagnosis of unspecified dementia, unspecified severity, without behavioral disturbance, mood disturbance, and anxiety.
On 07/31/23, Resident #12's bed had a Halo ring on one side.
Resident #12's physician's order dated 03/12/22, documented may use Halo for bed mobility.
Resident #12's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails was dated 09/22/22.
The assessment indicated the resident had falls, dementia or decreased cognition or delirium, and the resident required a low bed or bed alarm for safety from falls and therefore, the device was a restraint.
Resident #12's clinical record lacked documented evidence of a Restraint Assessment, a restraint care plan, or a restraint reduction plan initiation.
Resident #12's clinical record lacked documented alternatives were tried prior to installation, and a care plan for side rails and/or Halos.
Resident #12's Bedrail Consent, dated 07/26/21, lacked an explanation of risks and benefits.
Resident #14
Resident #14 was admitted to the facility on [DATE] and readmitted on [DATE], with diagnoses including dementia, and overactive bladder.
On 07/31/23, Resident #14's bed had a Halo on the right side.
Resident #14's physician's order dated 08/02/23, documented may have Halo for bed mobility.
Resident #14's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails was dated 06/17/23.
The assessment indicated the resident had dementia or decreased cognition or delirium and therefore, the device was a restraint.
Resident #14's clinical record lacked documented evidence of a Restraint Assessment, a restraint care plan, or a restraint reduction plan initiation.
Resident #14's clinical record lacked documented alternatives were tried prior to installation, and a care plan for side rails and/or Halo s.
Resident #15
Resident #15 was admitted to the facility on [DATE] with a diagnosis of adult failure to thrive.
On 07/31/23, Resident #15's bed had a Halo on the side.
Resident #15's physician's order dated 08/02/23, documented may have Halo ring for bed mobility.
Resident #15's clinical record lacked documented evidence of a Halo Mobility Ring Assessment, a signed consent that explained risks and benefits, alternatives were tried prior to installation, and a care plan for side rails and/or Halos.
Resident #16
Resident #16 was admitted to the facility on [DATE] and readmitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, with other behavioral disturbances and multiple falls.
On 07/31/23, Resident #16's bed had a Halo on the left side.
Resident #16's physician's order dated 08/02/23, documented may have Halo for bed mobility.
Resident #16's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails was dated 08/05/22.
The assessment indicated the resident had dementia or decreased cognition or delirium and history of falls and therefore, the device was a restraint.
Resident #16's clinical record lacked documented evidence of a Restraint Assessment, a restraint care plan, or a restraint reduction plan initiation.
Resident #16's Bedrail Consent, dated 10/31/22, lacked an explanation of risks and benefits.
Resident #16's clinical record lacked documented alternatives were tried prior to installation, and a care plan for side rails and/or Halos.
Resident #17
Resident #17 was admitted to facility on 04/10/23, with a diagnosis of dementia in other diseases classified elsewhere, unspecified severity, with mood disturbance.
On 07/31/23, Resident #17's bed had Halo s on each side of the bed.
Resident #17 physician's order dated 04/10/23, documented may use Halo for bed mobility.
Resident #17's clinical record lacked documented evidence of a Halo Mobility Ring Assessment, a signed consent that explained risks and benefits, alternatives were tried prior to installation, and a care plan for side rails and/or Halos.
Resident #171
Resident #171 was admitted to the facility on [DATE], with a diagnosis of dementia.
On 07/31/23, Resident #171's bed had Halo s on each side of the bed.
Resident #171 physician's order dated 08/02/23, documented may use Halo for bed mobility.
Resident #171's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails was dated 06/27/23.
The assessment indicated the resident had a history of falls and therefore, the device was a restraint.
The assessment lacked documentation the resident had a diagnosis of dementia.
Resident #171's clinical record lacked documented evidence of a Restraint Assessment, a restraint care plan, or a restraint reduction plan initiation.
Resident #171's clinical record lacked documented evidence a signed consent that explained risks and benefits, alternatives were tried prior to installation, and a care plan for side rails and/or Halos.
Resident #172
Resident #172 was admitted to the facility on [DATE], with a diagnosis of Parkinson's disease.
On 07/31/23, Resident #172's bed had Halo s on each side of the bed.
Resident #172 physician's order dated 06/22/23, documented may use Halo for bed mobility.
Resident #172's Restraint vs Enabling Device Bed Rail Safety Resident Assessment and Need for Side Rails was dated 06/22/23.
The assessment indicated the resident had a history of falls and therefore, the device was a restraint.
Resident #172's clinical record lacked documented evidence of a Restraint Assessment, a restraint care plan, or a restraint reduction plan initiation.
Resident #172's clinical record lacked documented evidence a signed consent that explained risks and benefits, alternatives were tried prior to installation, and a care plan for side rails and/or Halo s.
On 08/02/23 at 9:18 AM, the Skilled Nursing Facility (SNF) Manager verbalized upon admission, if a resident had issues with mobility, the facility would obtain an order from the physician for a Halo ring and have the Halo ring installed. The SNF Manager confirmed the facility did not attempt alternatives prior to installation.
On 08/02/23 at 10:05 AM, the SNF Manager verbalized the Halo Mobility Ring Assessment did not contain an assessment for entrapment. The SNF Manager explained the Halo Mobility Ring Assessment assesses if the resident's head could get stuck but did not assess for overall risk of entrapment.
On 08/02/23 at 10:42 AM, the SNF Manager verbalized the Halo Mobility Ring Assessment had a section of questions, when answered yes, would prompt the facility to complete a restraint assessment, a restraint care plan, and a restraint reduction plan initiated. The SNF Manager confirmed for residents whose assessments indicated a yes as an answer to those questions, restraint assessments and restraint care plans were not completed, and restraint reduction plans were not initiated.
On 08/03/23 at 10:55 AM, the SNF Manager verbalized alternatives were not attempted prior to installing bed rails. The SNF Manager explained upon admission, if the resident was unable to get in and out of bed independently, the facility would get an order from the physician for a Halo device to be installed. The SNF Manager confirmed residents were given Halo Mobility Rings upon admission, prior to attempting alternatives.
The SNF Manager verbalized residents with Halo Mobility Rings and side rails should have consents explaining the risks and benefits, a physician's order, and care plans for mobility that include the Halo ring. The SNF Manager confirmed not all residents had Halo Mobility Assessments completed, physician's orders, consents that explained the risks and benefits, and care plans for mobility that included the Halo Mobility Ring.
The facility policy titled Restraints, revised 10/31/18, documented all residents had the right to be free from physical restraints. Restraints should only be used where alternative methods were not sufficient to protect residents from injury and are not a substitute for less restrictive forms of protective restraint. All residents would have an assessment performed to determine the safety and protective needs of the resident prior to the application of restraints or medical protective device and at least every 90 days.
Bedrail Assessment
-
All residents will be assessed for safe use, the need for side rails, and determination of their use being a restraint or one that enhances the resident's independence and mobility, prior to adding bedrails to the bed and before use, using the Restraints vs Enabling Device Bed Rail Safety and Need for Side Rails Assessment admission and quarterly.
-
Competent residents desiring side rails for mobility may have them after assessment and completion of the Bed Rail Safety Guidelines and Need for Side Rails Assessment.
-
All side rail use must be care planned, have a physician's order, and address reduction and monitoring of residents during use and an informed consent outlining the advantages and disadvantages of side rails.
-
Reduction of bed rail use using alternative methods must be attempted prior to use and assessed quarterly when the resident Minimum Data Set was completed.
Medical conditions that warrant the use of restraints must be documented in the resident's medical record, ongoing assessments, and care plans. The physician's order alone was not sufficient to warrant the use of the restraint. For those residents whose care plans indicate the need for restraints, there would be a systematic and gradual process toward reducing restraints. This systematic process would also apply to recently admitted from who restraints were used in the previous setting.
CONCERN
(F)
Potential for Harm - no one hurt, but risky conditions existed
Medication Errors
(Tag F0758)
Could have caused harm · This affected most or all residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Resident #4
Resident #4 was admitted to the facility on [DATE], and re-admitted on [DATE], with diagnoses including unspecified ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Resident #4
Resident #4 was admitted to the facility on [DATE], and re-admitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, with psychotic disturbance, and major depressive disorder, recurrent, in remission, unspecified.
Resident #4's clinical record documented the following psychotropic orders:
-[DATE], Mirtazapine oral tablet 7.5 mg, give 7.5 mg by mouth at bedtime related to insomnia, unspecified.
-[DATE], duloxetine hcl oral capsule delayed release sprinkle 30 mg, give 1 capsule by mouth one time a day related to major depressive disorder, recurrent, in remission, unspecified.
Resident #4's care plan for the antidepressant medication, initiated on [DATE], included the following interventions:
-Educate Resident #4 and guardian about risks, benefits, and the side effects and/or toxic symptoms of duloxetine.
-Give antidepressant as ordered by physician.
-Monitor/document side effects and effectiveness. Antidepressant side effects: dry mouth, dry eyes, constipation, urinary retention, suicidal ideations.
-Monitor/document/report to physician ongoing signs/symptoms of depression unaltered by antidepressant meds: sad, irritable, anger, never satisfied, crying, shame, worthlessness, guilt, suicidal ideations, negative mood/comments, slowed movement, agitation, disrupted sleep, fatigue, lethargy, does not enjoy usual activities, changes in cognition, changes in weight/appetite, fear of being alone or with others, unrealistic fears, attention seeking, concern with body functions, anxiety, constant reassurance.
Resident #4's care plan for the antidepressant medication, initiated on [DATE], and revised on [DATE], documented the following interventions:
-Resident #4 took prescribed antidepressant and anxiety medication duloxetine related to depression.
-Monitor for signs and symptoms of anxiety: irritability, restlessness, uncontrolled worrying, difficulty sleeping, fatigue, etc.
-Monitor/document/report to physician ongoing signs/symptoms of depression unaltered by antidepressant meds: sad, irritable, anger, never satisfied, crying, shame, worthlessness, guilt, suicidal ideations, negative mood/comments, slowed movement, agitation, disrupted sleep, fatigue, lethargy, does not enjoy usual activities, changes in cognition, changes in weight/appetite, fear of being alone or with others, unrealistic fears, attention seeking, concern with body functions, anxiety, constant reassurance.
Resident #4's clinical record lacked documented evidence of a resident-centered care plan for the diagnosis of insomnia, unspecified, the use of a psychotropic to treat the diagnosis, or monitoring for specific behaviors or adverse affects related to the medication.
On [DATE] at 10:03 AM, an LPN confirmed Resident #4 did not have a care plan specific to the diagnosis of insomnia, unspecified, the specific medication prescribed, interventions used, behavior monitoring, and signs and symptoms monitoring related to the use of a psychotropic medication and should have.
On [DATE] at 2:36 PM, the ADON verbalized behavior monitoring was general and was not specific to a prescribed medication.
Based on interview, clinical record review, and document review, the facility failed to ensure residents did not receive unnecessary psychotropic medications when the facility lacked specific indications for use, monitoring of the behaviors associated with the psychotropic medications, and monitoring for adverse side effects for 11 of 11 residents receiving psychotropic medications (Resident #1, #3, #5, #6, #7, #9, #12, #14, #4, #13, and #16), residents did not receive an increase in a hypnotic medication related to environmental factors and resident request and a gradual dose reduction was attempted despite resident request to continue all psychotropic medications for 2 of 11 residents receiving psychotropic medications (Resident #14 and #16), and as needed (PRN) physician ordered psychotropics had a 14 day stop date for 1 of 11 residents receiving psychotropic medications (Resident #12).
Findings include:
Resident # 1
Resident #1 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, without behavior/psychosis/mood/anxiety and major depressive disorder, single episode, unspecified.
Resident #1's physician orders for psychotropic medications were as follows:
-[DATE] buspirone (hydrochloric acid) HCl oral tablet, give 5 milligrams (mg) by mouth one time a day for anxiety related to unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety and give 5 mg by mouth at bedtime for anxiety.
-[DATE] sertraline HCl oral tablet 25 mg, give 25 mg by mouth at bedtime related to major depressive disorder, single episode, unspecified.
-[DATE] sertraline HCl tablet 100 mg, give 100 mg by mouth at bedtime related to major depressive disorder, single episode, unspecified.
Resident #1's physician's orders lacked identified behaviors associated with the administration of buspirone, and sertraline, and adverse side effects to be monitored.
Resident #1's comprehensive care plans included the following related to psychotropic medications:
Initiated [DATE], Resident #1 was prescribed sertraline and buspirone for anxiety/agitation due to evening behaviors and anxiety through the early morning verbal/physical aggressive behaviors.
The care plan documented the following interventions:
-Resident #1 was to take the medications as prescribed.
-Nursing staff to monitor and assess for any side effects.
Initiated [DATE], Resident #1 was prescribed sertraline and alprazolam for depression and Depakote for Seizures.
The care plan documented the following interventions:
-Decrease dosage of psychotropic drugs as per orders until signs or tardive
dyskinesia disappears.
-Monitor drug blood levels as per orders.
-Monitor for signs of tremor.
-Monitor interaction or resident with others for appropriateness.
-Monitor resident's mental status functioning on ongoing basis.
The care plans did not differentiate the behaviors associated with sertraline, buspirone and alprazolam. The resident did not have an active order for alprazolam. The care plan lacked the specific adverse side effects to be monitored for buspirone HCl, and sertraline HCl.
Resident #1's Progress Notes documented the following Black Box warnings for psychotropic medications:
-[DATE] The system identified a black box warning for the following order:
Sertraline HCl oral tablet 25 mg Warning: Closely monitor all antidepressant-treated patients for clinical worsening and for emergence of suicidal thoughts and behaviors.
The facility lacked documented evidence the Black Box warnings for adverse side effects were monitored for Resident #1.
The facility lacked adequate monitoring for efficacy and adverse consequences for the four physician ordered psychotropic medications.
Resident #3
Resident #3 was admitted to the facility on [DATE], with diagnoses including bipolar disorder, unspecified, major depressive disorder, single episode, unspecified, other specified mental disorders due to known physiological condition, and other specified problems related to psychosocial circumstances.
Resident #3's psychotropic physician orders included the following:
-[DATE] Effexor XR Capsule Extended Release 24 Hour 75 mg, give three capsules by mouth one time a day related to bipolar disorder, unspecified.
-[DATE] Mirtazapine tablet 15 mg, give one tablet by mouth at bedtime related to major depressive disorder, single episode, unspecified.
-[DATE] aripiprazole tablet 2 mg, give one tablet by mouth at bedtime related to bipolar disorder, unspecified.
Resident #3's physician's orders lacked identified behaviors associated with the administration of Effexor XR, Mirtazapine, and aripiprazole and adverse side effects to be monitored.
Resident #3's comprehensive care plans included the following related to psychotropic medications:
Initiated on [DATE], Resident #3 was prescribed Effexor, Aripiprazole, and Mirtazapine to help alleviate signs and symptoms of bipolar and major depression disorder.
The care plan documented the following interventions:
-Blood levels were within normal range.
-Resident #3's provider/Medical Director (MD) was to be given pharmacy recommendations and make following determination.
-Maintain overall good mood/behavior.
-Medications were to be monitored and assessed by the pharmacist, provider, and Behavioral Health Services (BHS) psychiatry.
-Monitor and report if any side effects or physical conditions occurred as a result of long-term use.
The care plan lacked identified behaviors associated with the administration of Effexor, Aripiprazole, and Mirtazapine and the specific adverse side effects to be monitored.
Resident #3's Progress Notes documented the following black box warnings for psychotropic medications:
-[DATE] The system identified a black box warning for the following order:
Mirtazapine Tablet 15 mg Warning: Closely monitor all antidepressant-treated patients for clinical worsening and for emergence of suicidal thoughts and behaviors.
-[DATE] The system has identified a black box warning for the following order:
Effexor XR Capsule Extended Release 24 Hour 75 mg Warning: Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
-[DATE] The system has identified a black box warning for the following order:
aripiprazole tablet 2 mg Warning: Increased mortality in elderly patients with dementia-related psychosis. Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Aripiprazole is not approved for the treatment of patients with dementia-related psychosis. Closely monitor all antidepressant-treated patients for clinical worsening and for the emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.
The facility lacked documented evidence the Black Box warnings for adverse side effects were monitored for Resident #3.
The facility lacked adequate monitoring for efficacy and adverse consequences for the three physician ordered psychotropic medications.
Resident #5
Resident #5 was admitted to the facility on [DATE], with diagnoses including major depressive disorder, single episode, unspecified and major depressive disorder, recurrent severe without psych features.
Resident #5's psychotropic physician orders included the following:
-[DATE] citalopram hydrobromide oral tablet 20 mg, give 20 mg by mouth one time a day related to major depressive disorder, recurrent severe without psychotic features.
Resident #5's physician's order lacked identified behaviors associated with the administration of citalopram hydrobromide and adverse side effects to be monitored.
Resident #5's comprehensive care plans included the following related to psychotropic medications:
Initiated [DATE], Resident #5 was prescribed an anti-depressant medication.
The care plan documented the following interventions:
-Inform Guardian's office of any medication recommendations and for consent.
-Nursing staff monitor for side effects.
-Pharmaceutical recommendations be provided and assessed by Doctor/Provider.
-Staff to continue to provide non-medication interventions to help with mental/emotional wellbeing.
The care plan lacked identified behaviors associated with the administration of citalopram hydrobromide and adverse side effects for monitoring.
The facility lacked adequate monitoring for efficacy and adverse consequences for the physician ordered psychotropic medication.
Resident #6
Resident #6 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including insomnia, unspecified, anxiety disorder, unspecified, and major depressive disorder, recurrent, unspecified.
Resident #6's psychotropic physician orders included the following:
-[DATE] duloxetine HCl oral capsule delayed release particles 60 mg, give one capsule by mouth two times a day related to major depressive disorder, recurrent, unspecified.
-[DATE] buspirone HCl oral tablet 15 mg, give one tablet by mouth every six hours related to major depressive disorder, recurrent, unspecified.
-[DATE] Abilify oral tablet 5 mg, give 2.5 mg by mouth one time a day related to major depressive disorder, recurrent, unspecified.
-[DATE] trazodone HCl oral tablet 150 mg, give 150 mg by mouth at bedtime for sleep.
Resident #6's physician's order lacked identified behaviors associated with the administration of buspirone, Abilify, and duloxetine and adverse side effects to be monitored for buspirone, Abilify, duloxetine and trazadone.
Resident #6's care plans for the psychotropic medications, initiated on [DATE], documented the following:
-Resident #6 took prescribed antidepressant and anxiety medications buspirone, Abilify, and duloxetine medications for depression and anxiety.
The care plan documented the following interventions:
-Monitor drug blood levels as per orders.
-Monitor interaction or resident with others for appropriateness.
-Monitor resident's mental status on an ongoing basis.
-Monitor Resident #6's mood, state, and behavior.
Resident #6 care plan for diagnosis of insomnia reported not sleeping well at night, initiated on [DATE], documented the following interventions:
-Resident #6 was to be provided non-medication interventions to help provide quality of sleep.
-Continue to encourage Resident #6 with activities during the day with preferred independent activities or when there are outings in the community.
-Encourage Resident #6 to do exercises.
-Resident #6 preferred to sleep with the TV on in a darkened room at night.
-Resident #6 took medication to help with sleeping at night.
The care plans lacked identified behaviors associated with the administration of buspirone, Abilify, and duloxetine and the specific adverse side effects to be monitored for buspirone, Abilify, duloxetine and trazadone.
Resident #6's psychotropic medications had the following Black Box warnings for adverse side effects:
-[DATE] trazodone HCl oral tablet 150 mg has triggered the following drug protocol alerts/warning(s):
The system has identified a possible drug interaction with the following orders:
buspirone HCl oral tablet 15 mg
Severity: Severe
Interaction: Additive serotonergic effects may occur during coadministration of buspirone and duloxetine HCl oral capsule delayed release particles 60 mg, fentaNYL Transdermal Patch 72 Hour 100 micrograms (MCG)/hour, and trazodone HCl Oral Tablet 150 mg, and the risk of developing serotonin syndrome may be increased.
duloxetine HCl oral capsule delayed release particles 60 mg
Severity: Severe
Interaction: Serotonergic effects of trazodone and serotonin/norepinephrine reuptake inhibitors (SNRIs) may be additive. The risk of serotonin syndrome/toxicity may be increased.
The system has identified a black box warning for the following order:
trazodone HCl oral tablet 150 mg
Warning: Suicidal thoughts and behaviors. Closely monitor all antidepressant-treated patients for clinical worsening and for emergence of suicidal thoughts and behaviors.
The facility lacked documented evidence the Black Box warnings for adverse side effects were monitored for Resident #6.
Resident #6's Electronic Medical Record (EMR) lacked documented evidence the resident had experienced insomnia in [DATE] and indicated No Behaviors Observed from [DATE]-[DATE].
Resident #6's Behavior Progress Notes lacked documented evidence of insomnia related behaviors for [DATE].
Resident #6's Psychoactive Medication Review Progress Note, dated [DATE], documented the resident endorsed fatigue and irritability secondary to frustration with roommate .Trazodone was increased from 100 mg at night (HS) to 150 mg HS due to ongoing sleep issue.
On [DATE] at 3:49 PM, the Skilled Nursing Facility (SNF) Manager explained trazadone was increased per the resident request in [DATE] from 100 mg to 150 mg. There should have been tracking and monitoring for insomnia. There should have been behavior notes on the insomnia. The March behavior flow sheets and the April behavior tracking in the EMR did not reflect an issue with insomnia.
On [DATE] at 4:06 PM, the SNF Manager confirmed the psychotropic medications listed on Resident #6's care plan did not reflect a specific diagnosis and behavior associated with the specific medication. The care plan did not specify if Buspirone, Abilify, and duloxetine were administered for depression or anxiety. Anxiety and depression did not have documented signs and symptoms from the physician associated with the medication.
The facility lacked adequate monitoring for efficacy and adverse consequences for the four physician ordered psychotropic medication.
Resident #7
Resident #7 was admitted to the facility on [DATE] and readmitted on [DATE] with diagnoses including major depressive disorder, single episode, unspecified and altered mental status, unspecified.
Resident #7's psychotropic physician orders documented the following:
-[DATE] Seroquel Tablet 25 mg (quetiapine fumarate), give one tablet by mouth two times a day related to unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety.
Resident #7's physician's orders lacked identified behaviors associated with the administration of Seroquel and adverse side effects.
Resident #7's care plan for the psychotropic medications, initiated on [DATE], documented the following:
-Resident #7 was prescribed Seroquel for depression, at times maybe prescribed short term medications such as Ativan or other psychotropic medications dependent upon changes in mood/behavior.
The care plan documented the following interventions:
Administer medications as ordered.
Document changes in moods and behaviors.
Gradual dose reduction as per policy.
Monitor and record adverse effects of medication every shift.
Monitor and record behaviors every shift.
Notify physician of increase in agitation, mood, or behaviors.
Obtain and maintain consents from her guardian.
Pharmacy review of medications every month.
Staff assist with mental/emotional wellbeing through encouragement to participate in group and/or 1:1 activities and assist if needed to a less stimulating environment.
The care plan lacked identified behaviors associated with the administration of Seroquel and adverse side effects to be monitored.
Resident #7's psychotropic medications had the following Black Box warnings for adverse side effects:
Note Text: The system identified a black box warning for the following order:
Seroquel Tablet 25 MG (quetiapine fumarate)
Warning: Increased mortality in elderly patients with dementia-related psychosis.
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Quetiapine is not approved for the treatment of patients with dementia-related psychosis. Suicidal thoughts and behavior. In patients of all ages who have started on antidepressant therapy, monitor closely for clinical worsening and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.
The facility lacked documented evidence the Black Box warnings for adverse side effects were monitored for Resident #7.
On [DATE] at 2:27 PM, the SNF Manager explained Resident #7 had a behavior of calling out frequently. The SNF Manager reviewed Resident #7's physician's order for Seroquel and confirmed the behavior was not identified for the purpose of administering the medication.
On [DATE] at 2:30 PM, the SNF Manager explained Resident #7's Seroquel was increased to two times a day due to increased agitation. Agitation was exhibited by calling out. Calling out was part of the behavior of dementia.
On [DATE] at 2:37 PM, the SNF Manager confirmed Resident #7 was not monitored for specific behaviors or adverse side effects associated with Seroquel.
Agitation as evidence by calling out had not been identified by the physician as indication for use of Seroquel, monitored as the identified behavior, and Black Box warnings of adverse side effects were not monitored.
The facility lacked adequate monitoring for efficacy and adverse consequences for the physician ordered psychotropic medication.
Resident #9
Resident #9 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including major depressive disorder, single episode, unspecified.
Resident #9's psychotropic physician orders documented the following:
-[DATE] citalopram hydrobromide oral tablet 20 mg, give one tablet by mouth one time a day related to major depressive disorder, single episode, unspecified.
-[DATE] bupropion HCl oral tablet 75 mg, give 75 mg by mouth one time a day related to major depressive disorder, single episode, unspecified.
Resident #9's physician's orders lacked identified behaviors associated with the administration of citalopram hydrobromide and bupropion HCI and adverse side effects associated with the medications.
Resident #9's care plan for the psychotropic medications, initiated on [DATE], documented the following:
Resident #9 was prescribed anti-depressant medication for treatment of depression.
The care plan documented the following interventions:
Resident #9 was to attend BHS psychiatry appointments to assess and provide recommendations to provider.
Evaluate effectiveness and side effects of medications for possible decease/ elimination of psychotropic drugs.
Monitor drug blood levels as per orders.
Monitor resident mood state/ behavior.
Monitor resident's mental status functioning on ongoing basis.
Non-medication related interventions continue to be implemented such as counseling services and offering/providing activities, etc.
The care plan lacked specific anti-depressant medications and the identified behaviors associated with the administration of the medications and adverse side effects to be monitored.
Resident #9's psychotropic medications had the following Black Box warnings for adverse side effects:
-[DATE] bupropion HCl Oral Tablet 75 mg (Bupropion HCl)
Warning: Suicidality and antidepressant drugs. In patients of all ages who are started on antidepressant therapy, monitor closely for worsening and for emergence of suicidal thoughts and behaviors. Advise families and caregivers of the need for close observation and communication with the prescriber.
-[DATE] bupropion HCl oral tablet 75 mg (Bupropion HCl) has triggered the following drug protocol alerts/warning(s):
The system has identified a possible drug interaction with the following orders:
citalopram hydrobromide oral tablet 20 mg
Severity: Severe
Interaction: Plasma concentrations and pharmacologic effects of citalopram hydrobromide oral tablet 20 mg may be increased by bupropion HCl oral tablet 75 mg.
-[DATE] citalopram hydrobromide oral tablet 20 mg
Warning: Suicidal thoughts and behaviors. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.
Resident #9's clinical record lacked evidence the Black Box warnings of adverse side effects were monitored.
The facility lacked adequate monitoring for efficacy and adverse consequences for the two physician ordered psychotropic medication.
Resident #12
Resident #12 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including unspecified dementia, unspecified severity, without behavior/psychosis/mood/anxiety, major depressive disorder, single episode, unspecified, anxiety disorder, unspecified, and insomnia, unspecified.
Resident #12's psychotropic physician orders documented the following:
-[DATE] lorazepam oral concentrate 1 mg/0.5 ml, give 0.5 ml by mouth every six hours as needed (PRN) for anxiety.
Resident #12's Medication Regimen Review note, dated [DATE], completed by the Pharmacist, documented consideration to add duration to PRN lorazepam had been made to the psychotropic medication review form.
Resident #12's physician's orders lacked identified behaviors associated with the administration of lorazepam and adverse side effects associated with the medication.
Resident #12's care plan for anxiety disorder, initiated on [DATE], documented the following:
Resident #12 was diagnosed with anxiety disorder with signs and symptoms of continual fears/worries, irritability, fatigued, restlessness, difficulty concentrating, etc.
The care plan documented the following interventions:
Assist with verbalization of feelings.
Continue to encourage normal daily routines.
Resident #12 continues with counseling services through BHS.
Encourage to engage in conversation with fellow residents.
Offer a cold damp wash cloth for Resident #12 to wipe face.
Per resident's conversation with counselor, offer Resident #12 a piece of ice to hold in the resident's hand for 10 seconds.
Staff support Resident #12 through active listening skills.
Resident #12's care plans lacked a care plan for the psychotropic medication ordered for anxiety and the anxiety disorder care plan lacked evidence of a pharmacological intervention associated with behaviors.
Resident #12's psychotropic medications had the following Black Box warnings for adverse side effects:
-[DATE] The system identified a black box warning for the following order:
lorazepam oral concentrate 1 mg/0.5 ml
Risks from concomitant use with opioids. Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death. Follow patients for signs and symptoms of respiratory depression and sedation.
Resident #12's clinical record lacked evidence the Black Box warnings of adverse side effects were monitored.
Resident #12's Medication Administration Records documented the resident received lorazepam on the following dates:
-[DATE]
-[DATE]
-[DATE]
-[DATE]
-[DATE]
-[DATE]
-[DATE]
On [DATE] at 2:40 PM, the MDS Coordinator verbalized the Lorazepam order should have had a 14 day stop date because it was ordered as needed.
On [DATE] at 2:46 PM, the MDS Coordinator confirmed the resident did not have a care plan for the use of lorazepam specifically.
On [DATE] at 2:50 PM, the MDS Coordinator verbalized the resident had received Lorazepam two times in July and five times in August.
On [DATE] at 2:49 PM, the MDS Coordinator explained the physician signed the psychotropic medication review form acknowledging the pharmacist had read the recommendation from the pharmacist to add the end date to the PRN lorazepam. However, the physician did not respond or document a clinical rationale to the Pharmacist recommendation. Nursing was not directed to add an end date.
On [DATE] at 2:53 PM, the MDS Coordinator explained Resident #12 became anxious by exhibiting restlessness and confirmed the physician's order did not reflect the specific indication for use related to the behavior.
The facility lacked adequate monitoring for efficacy and adverse consequences for the physician ordered psychotropic medication.
Resident #14
Resident #14 was admitted to the facility on [DATE], and readmitted on [DATE], with diagnoses including major depressive disorder, single episode, unspecified and insomnia, unspecified.
Resident #14's psychotropic physician orders documented the following:
-[DATE] duloxetine HCl oral capsule delayed release sprinkle 60 mg, give one capsule by mouth one time a day for major depressive disorder related to major depressive disorder, single episode, unspecified.
-[DATE] Cymbalta Oral Capsule Delayed Release Particles 30 mg (duloxetine HCl), give 1 capsule by mouth at bedtime for major depressive disorder related to major depressive disorder, single episode, unspecified.
-[DATE] haloperidol decanoate intramuscular solution 50 mg/ml, inject one vial intramuscularly starting on the 14th and ending on the 14th every month related to major depressive disorder, single episode, unspecified.
-[DATE] buspirone HCl tablet 15 mg, give 0.5 tablet by mouth three times a day related to major depressive disorder, single episode, unspecified, give 1/2 tab to = 7.5 mg.
-[DATE] trazodone HCl tablet 100 mg, give one tablet by mouth one time a day related to major depressive disorder, single episode, unspecified.
-[DATE] Abilify Tablet 5 mg (aripiprazole), give one tablet by mouth one time a day related to major depressive disorder, single episode, unspecified.
Resident #14's physician's orders lacked identified behaviors associated with the administration of the psychotropics and adverse side effects associated with the medication.
Resident #14's care plan for the psychotropic medications, initiated on [DATE], documented the following:
Resident #14 was prescribed anti-depressant and antipsychotic medications: trazadone, Abilify, and Cymbalta, buspirone, and Haldol injections related to depression.
The care plan documented the following interventions:
Educate Resident #14 and caregivers about risks, benefits, and the side effects and/or toxic symptoms of medications prescribed.
Give anti-anxiety medications ordered by physician. Monitor/document side effects and effectiveness. ANTIANXIETY SIDE EFFECTS: Drowsiness, lack of energy, Clumsiness, slow reflexes, Slurred speech, Confusion and disorientation, depression, dizziness, lightheadedness, impaired thinking and judgment, memory loss, forgetfulness, nausea, stomach upset, blurred or double vision. Paradoxical side effects: Mania, hostility, and rage, aggressive or impulsive behavior, hallucinations.
Monitor/record occurrence of for target behavior symptoms such as wandering and document per facility protocol.
Non-medication interventions be done such as attend counseling, encouraging to participate in activities, outings, or activities that help provide coping skills for Resident #14.
Resident #14 is taking anti-anxiety meds which are associated with an increased risk of confusion, amnesia, loss of balance, and cognitive impairment that looks like dementia, falls, broken hips and legs. Monitor for safety.
When exhibiting or reporting signs and symptoms of anxiety or mood symptoms/behaviors, Resident #14 is assisted by staff to help strengthen coping skills.
Resident #14's care plan identified the psychotropic medications as antianxiety medications. Duloxetine HCl oral capsule delayed release sprinkle, Cymbalta Oral Capsule Delayed Release Particles, haloperidol decanoate intramuscular solution, buspirone HCl, trazodone HCl, and Abilify were all physician ordered for a diagnosis of major depressive disorder, single episode, unspecified.
Resident #14's clinical record lacked a diagnosis of anxiety on the admission Record date [DATE].
Resident #14's MDS 3.0 assessment dated [DATE], Section I5700, lacked indication of anxiety disorder.
On [DATE] at 2:07 PM, The MDS Coordinator verified Resident #14 was not ordered medications for anxiety as an indication for use and confirmed anxiety was not indicated as a diagnosis for the resident.
On [DATE] at 2:09 PM, the MDS[TRUNCATED]
MINOR
(C)
Minor Issue - procedural, no safety impact
Deficiency F0847
(Tag F0847)
Minor procedural issue · This affected most or all residents
Based on interview and document review, the facility failed to ensure the required verbiage was in the facility's arbitration agreement.
Findings include:
On 08/01/23 at 10:42 AM, during the Resident ...
Read full inspector narrative →
Based on interview and document review, the facility failed to ensure the required verbiage was in the facility's arbitration agreement.
Findings include:
On 08/01/23 at 10:42 AM, during the Resident Council Interview, one resident verbalized the staff had asked the resident to sign an Arbitration Agreement. The resident signed it. The resident recalled having seen staff approach another resident for a signature.
On 08/01/23 at 1:55 PM, the Administrator explained the Arbitration Agreements were newly implemented as of May 2023. The Administrator was not aware the agreement needed to explicitly grant the resident or resident's representative the right to rescind the agreement within 30 calendar days of signing it. The Administrator confirmed the facility Arbitration Agreements lacked documentation of the right to rescind.
The Administrator verbalized all residents or resident representatives, to the Administrator's knowledge, had signed the agreement.